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Abstract 
 
Purpose:  Segmented-field electron conformal therapy is characterized by dose 
heterogeneity due to unmatched penumbra of abutted fields of differing energy.  The 
present work investigates the potential to decrease dose heterogeneity by approximately 
matching beam penumbra using energy-specific source-to-collimator distances (SCDs).  
It was hypothesized that a clinically practical, variable-SCD method that utilizes 
Cerrobend® custom inserts can deliver segmented-field electron conformal therapy in the 
energy range of 6-20 MeV with less than ±5% variation in dose spread in the abutment 
regions of hypothetical planning target volumes (PTVs), i.e. constrain the PTV dose to 
85%-105%.   
Methods:  A Varian 15x15-cm2 electron applicator was modified to allow energy-
dependent SCDs resulting in energy-dependent air gaps.  Air gaps were chosen based on 
theoretical calculations to approximately match penumbra for 6, 9, 12, 16, and 20 MeV 
beams at a depth of 1.5 cm in water.  Treatment plans developed for four simulated PTVs 
and a single patient using the variable-SCD applicator were compared to identical plans 
using the current constant-SCD applicator.  Dose plans for the simulated PTVs using the 
variable-SCD applicator with electron inserts cut with diverging edges were delivered to 
film in a polystyrene phantom to assess feasibility.         
Results:  Treatment planning results in the four simulated PTVs showed that dose 
homogeneity in agreement with the hypothesis can be achieved using the variable-SCD 
applicator.  Minimum dose was increased by an average of 4%, and maximum dose was 
decreased by an average of 4%.  On average, the standard deviation of the dose decreased 
by 29%, and D90-10 decreased by 32%.  Measured dose in the abutment regions for all 
 xii
four simulated targets using the modified applicator agreed well with TPS predicted dose.  
For the patient PTV, the variable-SCD applicator plan predicted a 14% increase in 
minimum dose, a 10% decrease in maximum dose, and a 22% reduction in both the 
standard deviation of the dose distribution and D90-10 as compared to the standard 
applicator plan. 
Conclusion:  The results of this study demonstrated that dose homogeneity in 
segmented-field electron conformal therapy can be substantially improved by using 
energy-dependent SCDs to match beam penumbra. 
 
 xiii
Chapter 1 
Introduction 
   
1.1  Electron Conformal Therapy 
Electron conformal therapy (ECT) is the use of one or more electron beams (1) to 
contain the PTV in the 90% dose surface, (2) to deliver as homogenous a dose 
distribution as possible or a prescribed heterogeneous distribution to the PTV, and (3) to 
deliver minimal dose to underlying critical structures and normal tissues.  Modulated 
electron therapy (MET) is the use of energy modulation and/or intensity modulation to 
achieve ECT.  Energy MET can be delivered using custom bolus (bolus ECT) or multiple 
abutted beams of different energies (segmented-field ECT) (Hogstrom et al. 2003a).  
Intensity modulated electron therapy (IMET) can be achieved with scanned electron 
beams (Lief, Larsson, and Humm 1996), electron multi-leaf collimators (eMLC) (Lee, 
Jiang, and Ma 2000, Hogstrom et al. 2004), few-leaf collimators (Al-Yahya et al. 2005), 
or multiple field cutouts.  IMET is presently impractical due to the lack of commercially 
available treatment delivery hardware (e.g. eMLC) and treatment planning software 
(Hogstrom et al. 2004).   
1.2  Bolus and Segmented-Field ECT 
Bolus ECT (Starkschall et al. 1991; Low et al. 1992) has been used since 1990 at 
The University of Texas MD Anderson Cancer Center to treat posterior chest wall 
sarcoma (Low et al. 1995), post-mastectomy chest wall (Perkins et al. 2001), and head 
and neck disease (Kudchadker et al. 2002, 2003), and that technology is presently being 
implemented into the Pinnacle treatment planning system (Philips Medical Systems, Inc, 
Andover, MA).  Segmented-field ECT, an alternative to bolus ECT, is the use of multiple 
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electron fields of differing energy and weight to deliver a dose distribution that conforms 
the 90% dose surface to the distal surface of the PTV (Hogstrom et al. 2003a).   
Zackrisson and Karlisson (1996) compared the quality of bolus ECT and 
segmented-field ECT treatment plans for electron irradiation of the post-mastectomy 
chest wall.  Bolus ECT always delivers a higher skin dose due to dose buildup occurring 
in the bolus material; this effect can be advantageous in some cases, but a limiting factor 
in others.  Segmented-field ECT does not inherently carry this effect; hence, in cases that 
require increased surface dose, the use of constant thickness bolus may be required, e.g. 
Superflab (Radiation Products Design, Inc, Albertville, MN).                
One advantage of bolus ECT is that continuous energy modulation can be 
achieved via variable bolus thickness (Figure 1a).  Conversely, segmented-field 
conformal therapy is at a disadvantage for energy modulation because most linacs offer 
only coarsely spaced energies (6, 9, 12, 16 and 20 MeV) corresponding to coarsely 
spaced R90 depths (defined as the depth of the distal 90% dose on the central-axis depth 
dose curve) in unit density tissue (1.8, 2.7, 3.6, 4.8 and 6.1 cm respectively).  Although 
there is no reason radiotherapy machines could not have finer spacing (e.g. 1 MeV), this 
current limitation might lessen the utility of segmented ECT.  One disadvantage to the 
continuous energy modulation of bolus ECT is that it uses a single beam energy.  The 
energy is selected to reach the deepest portion of the PTV, and this results in needless 
dose distal to shallow regions of the PTV due to increased R90-10 compared to that for 
segmented-field ECT. 
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 Figure 1: (a) Bolus conformal therapy using a single 20 MeV beam.  Hot 
spots of 110% are due to loss of side scatter equilibrium as a consequence 
of the steep gradient in the bolus material.  (b) Segmented-field conformal 
therapy.  The three beams share a common source position.  Hot spots of 
110% are due to abutment of beams of different energy having unmatched 
penumbra.  The reference point was used for dose normalization.  
[Zackrisson and Karlsson 1996] 
 
A significant obstacle to delivering clinically acceptable segmented-field ECT is 
abutment dosimetry.  Current clinical methods approach segmented-field ECT without 
modification of the beam penumbra, and this often produces dose variations (hot/cold 
spots) greater than ±5% from the ideal target volume dose spread (90% - 100%) (Figure 
1b).  These dose heterogeneities are due to the wider penumbra width of lower energy 
beams compared to higher energy beams, creating a hot spot (cold spot) just inside the 
edge of the high (low) energy field.  By employing more closely matched penumbras it 
should be possible to reduce dose heterogeneity in the abutment region to less than ±5% 
in most cases.   
Possible methods to modify (broaden) the penumbra are (1) introducing a scatter 
wedge at the beam edge (Kurup, Wang, and Glasgow 1992), (2) using a combed-tooth 
collimating edge (Kalend et al. 1985), and (3) increasing the air gap between collimator 
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and patient surface (Maor et al. 1985; Lachance, Tremblay, and Pouliot 1997).  From a 
practical perspective, because the typical electron field is irregularly shaped, the air gap 
method is the most viable method.  Therefore, in the present study, use of variable air 
gaps (i.e. energy-dependent) to improve abutment dosimetry for segmented-field ECT 
was investigated.  Although only Cerrobend® (Lipowitz metal) inserts are used in this 
study, the method could potentially be implemented using a variable-source-to-
collimation-distance (SCD) eMLC (Hogstrom et al. 2004). 
Two methods of varying the air gap are possible.  The variable source-to-surface-
distance (SSD) method uses the existing collimating system (i.e. Cerrobend® inserts in 
the applicator and constant SCD) and extends the SSD by moving the treatment table 
(Figure 2a).  This method, presently doable, suffers from the following deficiencies:  (1) 
different virtual source positions (with respect to the patient) for fields of different energy 
result in non-coincidence of beam edges and (2) it requires repositioning of the treatment 
table for each energy used.  The latter makes clinical implementation of the variable-SSD 
method impractical; therefore, the focus of this study was on the variable-SCD method.  
With the variable-SCD method (Figure 2b), the air gap is increased by varying the source 
to collimator distance (SCD), which eliminates the problem of beam non-coincidence and 
table repositioning, but requires use of redesigned electron applicators that can position 
the Cerrobend® insert at energy-specific SCDs.   
1.3  Hypothesis and Specific Aims 
The hypothesis of this research is that a clinically-practical, variable-SCD method 
that utilizes Cerrobend® custom inserts can deliver segmented-field ECT using electron 
beams in the energy range of 6-20 MeV with less than ±5% variation in dose spread in 
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abutment regions of the PTV for hypothetical PTVs, (i.e. constrain the PTV dose to 85%-
105%).  Four specific aims have been completed to test this hypothesis. 
 
   
(a) Virtual Sources 
Differ 
(b) Virtual Sources 
Coincide 
Figure 2: (a) The variable-SSD method with the inner edge of the lower 
energy beam (E1) abutted to the outer edge of the higher energy beam 
(E2) at the patient surface illustrates the effect of non-coincident edges as 
the gap between the two fields increases with depth.  (b) The variable-
SCD method for the same abutment scheme illustrates beam edge 
coincidence as beams share a common virtual source. [Note:  both 
schematics are in the reference frame of the patient.] 
 
Aim 1.  Design a geometry for providing approximately equal penumbra widths at a 
constant depth (≈1.5 cm)  for different energy beams for the variable-SCD 
method.  Design and fabricate the necessary hardware for the variable-SCD 
method by modifying a Varian 2100EX 15x15-cm2 applicator (Varian Medical 
Systems, Inc, Palo Alto, CA). 
Aim 2.   Verify that electron beams for the Varian 2100EX 6/18 radiotherapy accelerator 
(6, 9, 12, 16, and 20 MeV) are commissioned in the Philips Pinnacle treatment 
planning system so that its electron pencil-beam algorithm correctly calculates 
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dose in a water or polystyrene phantom for the standard and modified (variable-
SCD) collimating systems.   
Aim 3.    Develop a procedure for constructing Cerrobend® custom inserts with 
diverging edges for the modified, variable-SCD applicator, and assess the 
impact of fabrication inaccuracy by irradiating a film phantom with segmented-
fields of the same energy.  
Aim 4a.  Test and compare the dose homogeneity of standard beam delivery (constant 
SSD and constant SCD) with that of the variable-SCD method for 1-D 
segmented-fields for four hypothetical PTVs and assess a possible method for 
QA by comparing calculated with measured dose distributions for the 1-D 
segmented-field treatment plans.      
Aim 4b.  Illustrate the clinical potential of the variable-SCD method by comparing the 
dose homogeneity of standard beam delivery (constant SSD and constant SCD) 
with that of the variable-SCD method for 2-D segmented-fields for a patient 
case.         
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Chapter 2 
Methods and Materials 
 
2.1  Aim 1:  Design of Methods for Matching Penumbra 
Ideal abutment requires that the shape of the dose distributions in the abutted 
penumbras regions be broad, matched, and have a common virtual source (which is 
characteristic of the variable-SCD system) (Khan et al. 1991).  By using an increased air 
gap (decreased SCD), the penumbra shape of a higher energy beam can be broadened to 
approximately match that of a lower energy beam at a specified depth.  To determine the 
magnitude of air gaps necessary to achieve acceptable abutment dosimetry, penumbra 
width (P80-20 or P90-10 illustrated in Figure 3) was calculated using Fermi-Eyges theory 
(Hogstrom, Mills, and Almond 1981; Hogstrom 1986; Hogstrom 1996).  
 
 
 
Figure 3:  P90-10 and P80-20 illustrated using a measured 12 MeV beam 
profile at 3-cm depth for a 10x10-cm2 field size.  The profile has been 
normalized to 100% of the central-axis dose.         
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2.1.1  Theoretical Penumbra Width 
The energy-specific air gaps used in the implementation of the variable-SCD 
method were chosen based on theoretical calculations of penumbra width.  The penumbra 
width, which depends on energy, air gap (SSD - SCD), and depth, can be calculated from 
the beam sigma σx(z), a measure of the lateral spatial Gaussian distribution of electrons 
about the mean direction at a point in the x-y plane at depth z.  Hogstrom et al. (1981) 
showed that the penumbra width is related to the sigma of a normally incident point (or 
pencil) beam by:   
 
)(56.21090 zP xσ×=−
),(68.12080 zP xσ×=−
(1a) 
(1b) 
 
 
 
with σx given by: 
 ,)]()[()( 212
22
0 zAzLz xx ++= θσσ (2) 
 
where L0 (cm) is the air gap (SSD-SCD), z (cm) is depth in water, xθσ (radians) is the 
root-mean-square (RMS) spread of the projected angular distribution of a point beam at 
the collimator (due to scatter in the dual scattering foil system and air), and A2 is the 
second moment of the linear angular scattering power at depth z in water (characterizing 
scatter in the phantom) given by: 
 
.))((
2
1)(
0
2
2 ∫ ′′−′= z water zdzzzTzA (3) 
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The scattering power in water, Twater, was computed using Werner’s 
approximation:  Twater(E) = 4.525*E-1.78 (Werner 1982) and Harder’s relationship for 
electron energy at depth: E(z) = E0(1 – z/Rp) (Khan et al. 1991).  Thus, 
  
 ,)1(525.4)( 78.178.10,
−− ′−×=′ ppwater RzEzT (4) 
 
where Ep,0 is the most probable incident energy and Rp is the practical range.  Combining 
(3) and (4), 
 
.)()1(525.4
2
1)(
0
278.178.1
0,2 ∫ ′′−′−×= −−z pp zdzzRzEzA (5) 
 
A computer program, which accepts the air gap (L0) and initial beam energy (Ep,0) as 
input, was written using Microsoft Visual Studio to calculate the above quantities and 
output P90-10 and P80-20 as a function of depth.    
2.1.2  Variable-SCD Applicator 
Based on preliminary results of penumbra calculations, a 15x15-cm² electron 
applicator was modified to accept placement of Cerrobend® inserts at specific locations 
upstream from the conventional location (95-cm SCD, which gives a 5-cm air gap to 
isocenter).  The modified applicator (Figure 4) allowed for adjustable air gaps in 2-cm 
increments from 7.5 cm to 19.5 cm.  To minimize the potential for alignment errors, the 
modification was designed and machined to provide electron insert placement 
perpendicular to the beam axis (x-y plane) with ±0.13 mm accuracy.        
The variable-SCD applicator was designed as a series of shelves on which a frame 
holding an electron insert can be placed (Figure 5, see detailed drawings in Appendix A).   
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 Tabs 
Frame holding 
Cerrobend® insert 
Figure 4:  Photograph of modified 15x15-cm2 applicator from direction of 
Cerrobend® insert insertion.  The insert shown is positioned upstream 
from the standard location, creating a 11.5-cm air gap.   
  
 
Tab with hole 
Insert 
Frame 
Leg Back 
plate 
Beam Direction
Tab without  
hole 
Figure 5:  Side view sketch of the shelf structure of the modified 
applicator.   
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Each shelf is comprised of four tabs attached to four perpendicular legs.  Two of the four 
tabs have alignment holes that constrain the frame location via two alignment pins on the 
frame holding the Cerrobend® cutout.  Also, the aluminum insert frame includes two 
setscrews to ensure consistent placement of the Cerrobend® insert in the frame (Figure 
6).  To obtain a rigid structure, the two back plates, each holding two legs, were milled 
out of a single piece of aluminum.   
 
(a) 
(b) 
 
 
 
 
Alignment pins 
Setscrews 
Figure 6:  (a) Photograph of downstream side of the insert frame with a 
Cerrobend® insert.  Setscrews push the insert snugly against the opposite 
corner of the frame (the allen wrench indicates the location of one set 
screw).  (b) Photograph of aluminum insert frame.   
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2.2  Aim 2: Verification of Electron Beam Commissioning in TPS 
The goal of Aim 2 was to assess the ability of the electron pencil-beam algorithm 
commissioned in the Philips Pinnacle3 (version 7.4f) treatment planning system (TPS) to 
accurately compute dose in a water or polystyrene phantom using the standard and 
variable-SCD collimating systems.  Staff medical physicists at Mary Bird Perkins Cancer 
Center (MBPCC) commissioned the Pinnacle's implementation of the Hogstrom electron 
pencil beam algorithm for all beam energies (6, 9, 12, 16, and 20 MeV) on a Varian 
2100EX 6/18 radiotherapy accelerator (S/N 1251) for the standard applicator geometry 
according to the recommendations of Hogstrom and Steadham (1996).  The beam data for 
the variable-SCD applicator "Machine" in Pinnacle3 were assumed identical to that of the 
standard SCD (95 cm), with the exception of L0 and xθσ .  The actual energy-specific air 
gaps (called "drift distance" in the TPS) were used, and a small modification was made to 
xθσ for each beam to account for the new SCDs (Hogstrom 1982), i.e. 
stdSCD
SCD
xx
var22
θθ σσ =′ .   (6) 
Algorithm commissioning for the standard and variable-SCD methods were verified by 
comparing Pinnacle3 calculations with measured dose distributions for 4x4-cm2 and 
15x15-cm2 fields at 100-cm SSD.  Data comparisons for 110-cm SSD were not 
performed because the variable-SCD method uses a 100-cm SSD exclusively.     
2.2.1  Calculated Dose Distributions   
2.2.1.1  Hogstrom Pencil-beam Algorithm 
 The Pinnacle3 calculates three dimensional electron beam dose distributions using 
the 3D implementation (Starkschall et al. 1991) of the Hogstrom pencil-beam algorithm 
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(Hogstrom, Mills and Almond, 1981).  The algorithm models arbitrary field shapes using 
a collection of pencil beams (typically 2x2 mm2 projected to isocenter) defined at the 
level of final collimation.  The dose distribution for each pencil beam is modeled to 
include Fermi-Eyges multiple Coulomb scatter theory, beam divergence, and Collisional 
energy loss, the latter requiring a measured broad beam central-axis depth-dose curve for 
a rectangular field that approximates the field size to be calculated.  Off-axis ratios 
determined from measured beam profiles are used to weight pencil beams, hence 
accounting for beam non-uniformity.  A particularly useful feature of the Hogstrom 
pencil beam algorithm is its ability to account for the impact of arbitrary air gaps (SSD - 
SCD) on the beam penumbra without impacting its accuracy for dose effects due to the 
patient's irregular surface and internal heterogeneity.  
2.2.1.2  Treatment Planning Dose Distributions 
• Setup 
Dose distributions for all field size and energy combinations were calculated in 
the Philips Pinnacle3 TPS.  Beams were applied to the Pinnacle's generic water phantom 
using a 15x15-cm2 applicator with the gantry at 180° (beam direction perpendicular to the 
phantom surface).  The collimator was rotated from the default 180° to 90° with the block 
"rotate with collimator" option set to "no" for computation.  This allows for a higher 
resolution in beam edge placement in the transverse plane.  A dose grid of 151x151x80 
voxels with a voxel size of (0.2 cm)3 was used for all calculations.   
The nominal 100-cm source-to-axis distance (SAD) was used for computation.  It 
would have been preferable to use a 90-cm virtual source to axis distance to model the 
actual virtual source position of the Varian 2100EX (Shiu 1994).  Although the software 
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allows the user to specify the virtual source distance, the input value has no impact on 
algorithm output, i.e. 100 cm is used regardless. 
 To model the measurement phantom (hi-impact white polystyrene) the medium-
to-water linear collisional stopping power and linear scattering power ratio lookup table 
was modified to map polystyrene ratios to the density of water.  Ratios taken from data 
published in TG-25 (Table 1a) were inserted into the file NewElectronStoppingPower.db 
so that polystyrene ratios are used for densities of 0.98 to 1.02 g/cm3 (Table 1b).  TG-25 
specifies a polystyrene density of 1.054 g/cm3.  The measured mass density of our 
polystyrene phantom was 1.053 ± 0.003 g/cm3.  The CT number of the virtual phantom 
was 1024, which specified a density of 1 g/cm3 (Table 1c). 
• Data Analysis 
The TPS outputs the dose matrix to a binary file, from which the dose distribution in the 
central xz plane (y = 0) was extracted using in-house software.  These data were then 
converted to the format required by the SigmaPlot® contour plot feature.  Once imported 
into SigmaPlot®, dose distributions were normalized to 100% of the central-axis dose 
maximum, and 2D isodose plots and 1D dose profile plots were generated.  
2.2.2  Relative Dose Distribution Measurements 
2.2.2.1  Varian 2100EX Radiotherapy Accelerator 
 Electron beams of 6, 9, 12, 16 and 20 MeV were provided by a Varian 2100EX 
radiotherapy accelerator with a nominal source-to-axis distance (SAD) of 100 cm.  
2.2.2.2  Film Phantom 
 Beam data were acquired by irradiating a hi-impact, white opaque polystyrene 
(C8H8 + TiO2) film phantom (25.4 x 35.6 x 10 cm3) with 10x12 in (25.4 x 30.5 cm2)  
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Table 1a:  Polystyrene stopping power and scattering power ratios from 
TG-25 published data. 
  Water 
High-impact  
polystyrene 
(white-
opaque) Ratio 
Linear collision 
stopping power 
(MeV/cm) 1.968 2.01 1.021 
Linear angular 
scattering power 
(radian2/cm) 0.0695 0.0603 0.868 
 
Table 1b:  Stopping power and scattering power ratio lookup table used to 
calculate dose in a polystyrene phantom. 
Density (g/cm2) 
Linear collision 
stopping power 
Ratio 
Linear angular 
scattering 
power  
0.000 0.001 0.001 
0.291 0.311 0.292 
0.927 0.933 0.729 
0.980 1.021 0.868 
1.020 1.021 0.868 
1.047 1.051 1.040 
1.100 1.098 1.135 
1.427 1.422 1.863 
1.940 1.940 3.026 
7.000 7.000 9.900 
 
 
Table 1c:  CT number to density table used for dose computation. 
CT Number Density (g/cm3) 
0 0.000 
45 0.001 
255 0.195 
524 0.495 
963 0.967 
999 0.991 
1024 1.000 
1074 1.062 
1082 1.071 
1262 1.161 
1862 1.609 
15000 11.300 
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Kodak XV film (Figure 7).  Hi-impact, white polystyrene was chosen because of its near 
water equivalence (Khan et al. 1991).  Exact alignment (±0.1 mm) of the edge of the film  
 
 
 
 
(a) 
Alignment 
peg 
10"x12" Kodak XV film 
Velcro 
hooks 
25.4 cm 
35.6 cm 
Beam Direction 
5 cm
5 cm
Alignment hole 
Light opaque tape (b) Hinge Beam 
 
Figure 7:  (a)  Photo of the Hi-impact, white opaque polystyrene film 
phantom shown in open position with 10"x12" Kodak XV film loaded for 
dose measurement.  (b)  Phantom shown upright; note light opaque tape 
and plastic hinges that lie outside the radiation beam. 
 16
with the phantom surface is important to prevent electron scatter artifacts (Khan et al. 
1991).  For consistent and accurate film positioning (±0.1mm reproducibility) within the 
phantom, alignment holes were drilled in the film using an electric three hole punch 
(Swingline Model 525) allowing film placement to be guided by corresponding 
alignment pegs in the phantom.  A random error of 0.1 mm in the position of the 
alignment holes was determined by measuring the distance from film edge to the 
perimeter of the three alignment holes for six test films.  To make the phantom light tight, 
black opaque “3M Scotch Photographic Tape 235" was applied along the surface where 
the beam is incident.  The remaining perimeter of the phantom was covered with black 
felt attached to a permanent Velcro "hooks" lining (Bova 1990). 
2.2.2.3  Measurement Setup 
For film irradiation, the phantom was placed on the treatment table, which was 
adjusted so that the "hinged" surface was positioned at the appropriate source to surface 
distance (100-cm SSD) using the optical distance indicator.  Alignment along the x- and 
y-axes was done using the light field cross hairs such that the film lay in the plane of 
gantry rotation (xz plane, Figure 8).  Measurements were made with the gantry positioned 
at 180°.   
For fields using the nominal 5-cm air gap, Cerrobend® blocks were positioned in 
the standard 15x15-cm2 applicator such that the downstream surface of the block was 5 ± 
0.2 cm from isocenter.  For fields using the variable-SCD method, inserts were placed in 
the variable-SCD applicator at 7.5, 11.5, 17.5 and 19.5 cm from isocenter for 9, 12, 16, 
and 20 MeV beams respectively.   
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Figure 8:  Schematic of gantry and treatment room coordinate system.  
The gantry is positioned at 180°. “I” indicates isocenter.  The gantry 
rotates about the y-axis in the x-z plane.    
 
Initially a thin air gap (~0.25 mm) between the film and the phantom along the 
plane of the film resulted in poor agreement between measured and calculated %DD (cf. 
Figure 9).  This was due to scatter effects as described by Dutreix and Dutreix (1969).     
Figure 9:  Measured central-axis depth dose curves for a 12x12-cm2 12-
MeV beam.  The measured depth dose without the C-clamp (dashed line) 
shows the influence of approximately 0.25 mm air in the phantom along 
the surface of the film compared to the measured depth dose with the C-
clamp (solid line). 
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Subsequently, a large C-clamp was employed to compress the phantom and alleviate this 
issue.  The final measurement setup is shown in Figure 10 with the standard 15x15-cm2 
applicator.   
    
 
Figure 10:  The standard 15x15-cm2 applicator (with 10x10-cm2 insert) 
attached to the Varian 2100EX.  The film phantom is in measurement 
position with the C-clamp in place.   
 
2.2.3  Film Dosimetry 
All films used in this study were irradiated "edge on" with an exposure 
corresponding to a maximum central-axis dose of approximately 50 cGy, i.e. films were 
irradiated to the number of monitor units (MU) that would deliver a maximum central-
axis dose in water of 50 cGy.  This resulted in a maximum film optical density of 
approximately 1.5. 
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2.2.3.1  Analysis 
• Film Developing 
 All films were developed using a X-OMAT 270 RA processor.  Before use, the 
processor was allowed to warm up to a developer temperature readout of 94.2 ± 0.1°F, if 
necessary.  To ensure the processor temperature was stable and to eliminate any abnormal 
initial conditions (such as dust inside the film transport mechanism), four blank films 
were run through prior to processing irradiated films.  When processing a set of exposed 
films, the temperature readout was checked after every four to five films processed.  If 
the temperature reading deviated by more than ±0.2°F the temperature was allowed to 
stabilize before processing was resumed.                
• Readout 
The 2D distribution of exposure of each developed film was read using the Vidar 
DosimetryProTM Advantage 16-bit digitizer with a scanning resolution of 356 μm 
(corresponding to the average value of 16 89-μm pixels.)  Incandescent light transmitted 
through the film is registered by a linear array of 89-μm CCD detector elements.  The 
signal from each CCD element is recorded as a 16-bit (65,536 gray level) A/D value.  
RIT software version 4.2 was used to apply a 9x9 low pass filter to the calibration films 
and a 7x7 low pass filter to all other films to remove high frequency noise.  
• Data Analysis 
The 2D distribution of exposure was transformed to dose using the calibration 
curve, ie. D=D(OD), discussed in the next section.  Analysis of the measured 2-D dose 
distributions was performed using Microsoft SigmaPlot®  9.0 software.  To facilitate this, 
a central-axis depth dose curve and multiple cross axis profiles in 5-mm increments from 
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a depth of 5 mm to just beyond Rp were exported as text files for each film analyzed.  The 
files were then used to create a 2-D dose matrix formatted for the SigmaPlot® contour 
plot feature using in-house software.  In SigmaPlot®, dose distributions were normalized 
to 100% at Dmax, as determined from the film central-axis depth-dose data, and isodose 
plots were created.   
2.2.3.2  Calibration   
Calibration films were exposed perpendicular to the beam.  Khan et al. (1991) 
reported perpendicular and parallel film exposure give the same results under the correct 
conditions, i.e. no air gap between the film and the phantom and precise film edge 
placement for parallel exposure.  In accordance with common practice for relative film 
dosimetry measurements, a single calibration curve was created for each batch of film 
used (box of 50 films) ( Bos et al. 2002).        
Calibration curves were determined from 10 calibration points, created using four 
calibration films and applied to the measured dose distributions using RIT software.  The 
first calibration film was not irradiated, providing base + fog optical density level of the 
film.  The remaining packaged films were placed at R100 (the depth of maximum dose) 
for a 9 MeV beam (2 cm of Plastic Water®) and irradiated using a 10x10-cm2 insert in a 
standard 10x10-cm2  applicator, i.e. the setup for which the accelerator is calibrated to 
deliver 1 cGy/MU.   
The RIT software was used to generate calibration curves by creating a piecewise 
polynomial fit to the measured data.  To prevent the piecewise polynomial fit from 
underestimating dose (or estimating negative doses) at low exposures, the second 
calibration film was irradiated with 1 MU (1 cGy).  Four fields were delivered to the third 
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and fourth films.  The third film (illustrated in figure 11) received 10, 18, 26, and 34 MU, 
and the fourth received 42, 50, 58, and 66 MU.  The films were scanned and the average 
scanner value for a 2x2-cm2 box in the center of each field was correlated to the delivered 
dose to create points on the calibration curve.     
 
10 MU  18 MU 
34 MU 26 MU 
Figure 11:  Example of calibration film #3, used to generate four points on 
the calibration curve.  This film received 10, 18, 26 and 34 MU.  42, 50, 
58 and 66 MU were delivered in the same fashion to calibration film #4.      
 
Total dose to each field on the four-field films was as much as 3% greater than the 
direct dose delivered because of scattered and leakage dose from adjacent fields.  To 
determine the total dose, a single region of a film was irradiated to a high dose (Figure 
12) and scanner values at adjacent field locations were converted to optical density (OD) 
using the OD calibration step-wedge provided with the scanner.   
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 OD3/6  D6 = 100 cGy
OD4/6 OD5/6
Figure 12:  Scanned film used to account for scatter and leakage dose 
contributions to the calibration fields.  The dark area received 100 MU 
under reference conditions.  ODi/j denotes optical density to field i after 
the irradiation of field j.    
 
Scattered and leakage dose per monitor unit for adjacent fields was determined by 
converting the OD of regions adjacent to the high dose field into dose using the slope of 
the linear region of the dose response curve.  Because dose contributions to adjacent 
fields is proportional to monitor units, the total dose delivered to a field region was 
determined by summing the dose per monitor unit from adjacent fields.  For example, the 
dose to field 2, D2',  is given by (Figure 13): 
(7) 5/24/23/22
'
2 DDDMUD +++=
  
where Di/j is the dose to field i from field j: 
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S0 is the inverse of the slope of the linear dose response region (cGy/OD), ODBG is the 
background optical density, ODi/j is the OD at field i due to field j, and MUn is the 
monitor units delivered to field n.  Total dose, D', to fields 3, 4, and 5 were determined in 
the same way.   
 
 
D2' = MU2 + D2/3 MU3          + D2/4 + D2/5
MU5 MU4 
Figure 13:  Diagram of the dose contribution from adjacent fields to D2'. 
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The slope of the linear region of the dose response curve (Figure 14) was 
determined iteratively by implementing equations 7 and 8 in a spread sheet and plotting 
OD vs. dose.  OD values were determined by converting AD to OD using the OD 
calibration step-wedge.  The initial S0 was obtained from the slope of a linear regression 
of the OD vs. dose plot for the 0-MU, 10-MU, and 18-MU fields assuming no scattered 
and leakage dose.  Plotting the same curve with scattered and leakage dose to each field 
included gave a new S0 value which was used to recalculate total dose to each field.  This 
was repeated until the value of S0 changed by less than 0.003%.  Figure 15 shows an 
example of the AD (analog to digital pixel value) vs. dose curve with the piecewise 
polynomial applied to measured dose distributions by the RIT software; Table 2 lists the 
data for one calibration curve.    
 
Net OD vs. Dose
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Figure 14:  Dose response curve for XV film.  Background OD was 
subtracted from the raw value to give net optical density for this plot. 
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 Figure 15:  Example plot of AD value vs. dose for a ten-point calibration 
curve.  The 1-cGy point prevents the piecewise polynomial from 
prematurely intersecting the ordinate.  Note: the linear and spline fits were 
not used.    
 
Table 2:  Data for a ten-point calibration curve.  Monitor units delivered to 
each field are shown followed by total dose (D'), 16-bit analog to digital 
pixel value (AD), and optical density (OD).   
MU D' (cGy) AD OD 
0 0.0 44952 0.17 
1 1.0 41476 0.20 
10 10.21 18921 0.54 
18 18.18 10080 0.81 
26 26.20 5262 1.08 
34 34.17 3088 1.33 
42 42.49 1724 1.58 
50 50.46 1145 1.75 
58 58.48 730 1.96 
66 66.45 523 2.10 
 
The total dose to each region of the four-field films determined using the method 
described above was verified by ion chamber measurements.  A Slimline Microchamber 
(model A16) was placed under 2 cm of plastic water and scattered and leakage dose per 
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monitor unit from a high dose field was measured at adjacent field locations.  These data 
were used to calculate total dose for each field.  The total dose was also measured by 
placing the ion chamber at the location of each field and delivering the four field pattern.  
The results in both cases agreed with the results of the method described above within 
0.3%.  
2.3  Aim 3:  Construction of Cerrobend®  Blocks with Diverging Edges     
Each plan developed using segmented-field ECT required that at least one 
Cerrobend® insert be fabricated for each beam energy used.  Optimal abutment 
dosimetry requires that beam edges of adjacent beams exactly coincide.  One requisite to 
this is that the Cerrobend® inserts be fabricated with diverging edges.  This section 
describes how the electron inserts were fabricated with diverging edges and how the 
accuracy of fabricated edge placement was assessed. 
2.3.1  Block Fabrication with the Compu●cutter® System 
2.3.1.1  General 
Inserts were fabricated by molding Cerrobend® inside a steel frame with 
apertures defined by foam blocks, which is the standard method used in the MBPCC 
radiation therapy clinic.  Different from standard clinical practice for electron therapy, a 
computer-controlled hot wire system, Compu●cutter® system (Huestis Medical, Bristol, 
RI), was used to cut foam blocks with edges diverging from the virtual radiation source. 
The Compu●cutter® software accepts three geometric parameters (Figure 16):  
(1) the source-to-tray distance (STD), which is the distance from the radiation source to 
the bottom of the shielding tray;  (2) the source-to-film distance (SFD), which is the 
distance from the radiation source to the plane in which the field shape is defined 
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(isocenter in the present work), and (3)  the SAD, which is the distance from the radiation 
source to isocenter.  In the present work the radiation source is defined as the virtual 
source (Schröder-Babo 1983).  A 90-cm virtual SAD was assumed for simplicity through 
this work (Shiu et al. 1993) .  Therefore, the STD was 85 cm.  Because the desired field 
size is most easily defined at isocenter, a 90-cm SFD was used. 
 
STD = 85cm 
SAD = 90cm
SFD = 90 
Shielding Tray 
Virtual 
Radiation 
Source
Isocenter
1.4cm
5cm 
 
 
 
 
 
 
 
 
 
 
 
Figure 16:  Geometry used by the Compu●cutter® software to fabricate 
foam blocks for making Cerrobend® inserts.   
 
 The Compu●cutter® cuts field shapes in foam blocks using a four-axis servo 
controlled hot nichrome wire cutting mechanism.  To account for the melted material on 
either side of the hot wire (70° C), the "burn thickness" is measured and entered into the 
software.  The software then shifts the cutting wire away from the field by half the "burn 
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thickness."  In the present work a 0.4 mm diameter wire was used with a "burn thickness" 
of 0.97 mm.    
The RF digitizer normally used to input field shapes has a manufacturer quoted 
accuracy of 0.5 mm and input data points are subject to operator error.  Therefore, 
coordinates of points defining the aperture (simple square and rectangular field shapes in 
this study) were input manually, i.e. to simulate accuracy that could be expected if field 
shapes were transferred digitally from a treatment planning system.  
2.3.1.2  Blocks for Field Abutment 
Ideal abutment requires that beam edges coincide (Hogstrom 2003b).  Due to the 
sharp dose falloff in the penumbral region, slight beam-edge misalignments can result in 
large dose inhomogeneities.  For example, for a 12 MeV beam profile at a depth of 2 cm, 
the distance from the 45% to 55% dose point is approximately 1 mm.  Thus, two 12 MeV 
beams delivered with the standard 5-cm air gap and abutted with overlap of 1 mm will 
give rise to dose increase (hot spot) of approximately 10%.  Similarly, a gap of 1 mm will 
result in a dose decrease (cold spot) of approximately 10%.   
During block fabrication a primary source of error is inaccurate foam placement 
in the steel mold.  To reduce this positioning error, placement of the foam field shapes 
was guided by a computer printout of the field shape.  To accomplish this, points defining 
field shapes at isocenter for each beam were scaled by the factor (SCD-Tf)/SADvir, where 
Tf is the foam thickness (1.4 cm).  A plot of the resulting points (Figure 17) was then 
printed to scale and attached to the bottom plate of the steel frame (corresponding to the 
top of the Cerrobend insert).  The example in Figure 18 shows how the printouts were 
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attached to the bottom plate, the bottom plate attached to the steel frame with foam 
aligned to the printed outline, and the completed electron inserts.     
 
 
Figure 17:  Sample plot of the scaled field shapes used to guide placement 
of the foam field shapes.   
 
12 MeV (SCD = 78.5 cm)
20 MeV (SCD = 70.5 cm) 
 
(a) (b) 
Figure 18:  (a) Field shape printout taped to the bottom plate of the 15x15-
cm2 mold.  (b) The steel mold with foam in place.  The lead weight 
prevented movement of the foam when liquid Cerrobend® was poured 
into the frame.  (c) The resulting inserts for a single 20 MeV field (left) 
and two 12 MeV fields (right). (Figure continued) 
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 (c) 
2.3.2  Assessment of Accuracy of Block Fabrication Method 
The dosimetric impact of fabricating electron inserts as described in the previous 
section was assessed by irradiating the hi-impact polystyrene film phantom with 12x12-
cm2 fields consisting of two abutted 6x12-cm2 fields of the same energy.  For the method 
to be acceptable, the resulting dose distributions should be identical to within ±3% to that 
of a single field.   
For analysis, it was necessary to determine the impact of beam misalignment 
ΔD/Δx (%/mm) using the variable-SCD applicator.  ΔD, defined as the maximum percent 
dose difference between the off-axis profile for a single square field (normalized to 100% 
on central-axis) and that for two abutted fields (with identical penumbra), should occur at 
the location of the junction point xint (Figure 19). 
The profile for the abutted fields is normalized to agree with the off-axis profile 
for the single field at a dose point (DN) in a flat region of the off-axis profile, i.e. away 
from the abutment region.  ΔD is then given by:     
(9) }1/)]()({[%100(%) int2int1 −+×=Δ NFF DxDxDD
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where DF1(x) and DF2(x) are the doses due to fields 1 and 2 at off-axis position x, and xint 
is the off-axis profile intersection point.  DN is expected dose, i.e. the sum of the photon  
transmission dose for a fully blocked field and the dose for an open field; therefore, DN is 
greater than 100%.  For ideal abutment (ΔD = 0) of two fields, the percent dose of each 
field at the junction point should be DN/2.     
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Figure 19:  Illustration of ΔD and Δx using off-axis profiles at 1-cm depth 
for two 12 MeV beams with an 11.5-cm air gap and abutted on central-
axis (xint = 0) with Δx = +2 mm.  Note: Δx is measured as the distance 
between DN/2 dose points for each field, which is 51.3% in this example 
due to the photon dose contribution of ~2.6% for a 12 MeV beam at this 
depth.    
 
Beam gap or overlap is defined by Δx (Figure 19), with Δx < 0 indicating a field 
gap and Δx > 0 indicating a field overlap.  In order that Δx=0 corresponds to ΔD=0, Δx is 
defined as the off-axis distance between the DN/2 dose points along the abutment edge of 
each field: 
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Figure 20 plots ΔD vs. Δx for a 10x10-cm2, 12-MeV beam at 1-cm depth (dotted 
line).  In the range -5 mm < x < 5 mm, a linear regression showed the slope (ΔD/Δx) to 
be 8.5% mm-1, which can be used to assess the magnitude of Δx from ΔD.  In the present 
study, the air gap for each beam energy was chosen to achieve penumbra matching, thus 
ΔD/Δx for all energies was approximately equal at 1-cm depth, i.e. 8.0, 8.7, 8.5, 7.8, and 
8.8% mm-1  for 6, 9, 12, 16, and 20 MeV respectively.  Consequently, the impact of error 
in fabrication and placement of block edges should be independent of beam energy.  
Therefore, the study of this impact was restricted to 12 MeV in the present work. 
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Figure 20:  Dosimetric impact (ΔD) of beam gap/overlap (Δx) at 1-cm 
depth for abutment of two 12 MeV beams using the variable-SCD 
applicator with an 11.5-cm air gap.  The dotted line represents the 
calculated relationship derived from the lateral falloff of a film-measured 
profile.  The solid line represents a linear regression of the data for -5 < Δx 
< 5, yielding a slope of 8.48 %D/mm.     
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2.3.2.1  Accuracy and Precision of Off-axis Abutment Test 
The precision of abutment was ascertained at 2.5-cm off-axis (xint = 2.5 cm)  by 
irradiating 3 films with 3 independently fabricated rectangular pairs (8.5x12 cm2 and 
3.5x12 cm2).  ΔD was measured from the film profiles and Δx was calculated from 
Δx=ΔD(ΔD/Δx)-1.  While the sample standard deviation represents the precision of a 
single measurement, the mean dose error gives the accuracy at xint = 2.5 cm.     
2.3.2.2  Zero and 5-cm Off-axis Abutment Test 
 The impact of the location of and off-axis abutment on the accuracy of abutted 
edges was ascertained by placing field edges at 0-cm and +5-cm off-axis.  Hence, two 
insert pairs were fabricated (8.5x12 cm2 paired with 3.5x12 cm2,  and 6x12 cm2 paired 
with 6x12 cm2).  A single film was irradiated for each pair of inserts.  The precision of 
the data measured at 0-cm and +5-cm off-axis was assumed to be equal to that at +2.5-cm 
off-axis.  
2.3.2.3  Dosimetric Impact of Errors in Block Fabrication Test 
The expected effect of errors in block cutting was validated by measuring the 
error resulting from purposefully displaced field edges for central-axis abutment (xint = 
0).  Four separate block pairs (6x12 cm2 each) were fabricated with “errors” resulting in 
Δx values of ±2 mm  and ±4 mm by displacing each central-axis aperture edge by half the 
desired Δx.  For example, Δx of +2 mm was achieved by offsetting the central-axis edge 
of each insert by 1 mm toward the other field (Figure 21), resulting in hot spots.  
Conversely, offsetting the edges by 1 mm in the other direction resulted in Δx of -2 mm 
and a cold spot.  
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Figure 21:  Illustration of the field shapes used to fabricate Cerrobend® 
inserts for central-axis abutment with +2-mm overlap.  Central axis 
denoted by solid lines.  
 
2.4  Aim 4a:  Evaluate Dose Homogeneity in Simple Targets  
Δx = 2 mm 
The potential for the variable-SCD method to improve dose homogeneity was 
assessed using the Philips Pinnacle3 treatment planning system by studying simple 1D 
segmented-field plans for irradiation of four hypothetical planning target volumes 
(PTVs).  Each PTV was defined by a single slice (0.25-cm slice thickness) region of 
interest (ROI) in a virtual polystyrene phantom (50 x 50 x 50 cm3) to evaluate the method 
in the absence of common patient features (irregular surface, bone, air cavities, etc).  A 
second single-slice ROI called "Outside Target" was defined for each plan to aid in 
analysis of dose outside the PTV.  In all cases, the "Outside Target" ROI extended from 
the surface to 7 cm in depth (maximum depth of PTVs ranged from 4 to 5.5 cm) and ±8 
cm off-axis (all PTVs spread from -5 to 5 cm) with the PTV excluded.   
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Two trials were created for each hypothetical target, the first using the variable-
SCD method and the second using the standard method.  For comparison, all planning 
parameters (beam energy, field shapes and beam weight) were developed for the 
variable-SCD trial and copied exactly to the standard trial.  The ability to deliver each 
dose distribution calculated by Pinnacle3 using the variable-SCD method was evaluated 
by delivering the plan to the film phantom and measuring the dose distribution in the 
central xz plane.  The measurement and data analysis methods used in this section were 
identical to that used for verification of electron beam commissioning described in aim 2.      
2.4.1  Simple Targets 
2.4.1.1  Two-step Block Target 
The two-step block target represented in Figure 22 was chosen to assess the 
potential of the variable-SCD method to reduce dose heterogeneity when treating with 
two beam energies abutted near central-axis.  This target might approximate a typical 
volume targeted for postmastectomy irradiation, i.e. 4-cm depth simulating the internal 
mammary chain lymph nodes and 2.5-cm depth simulating the chest wall thickness.     
 
0.7cm
4cm 
10cm
2.5cm 
 
 
 
 
 
 
Figure 22:  Illustration of the two-step block target.  The dashed line 
represents the phantom surface.  
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2.4.1.2  Wedge Target 
The wedge target represented in Figure 23 was chosen to assess the potential of 
the variable-SCD method to reduce dose heterogeneity when treating with three adjacent 
beam energies abutted off-axis.     
 
 
 
 
 
 
 
 
0.7cm
5.5cm 
10cm
2.7cm
Figure 23:  Illustration of the wedge target.  The dashed line represents the 
phantom surface.  
 
2.4.1.3  Pentagon Target 
The pentagon target represented in Figure 24 was chosen to assess the potential of 
the variable-SCD method to reduce dose heterogeneity when treating with three beams of 
different energy abutted off-axis while conforming the 90% dose contour to a sharp 
gradient in target depth.    
2.4.1.4  Inverted Well Target    
The inverted well target represented in Figure 25 was chosen to assess the 
potential of the variable-SCD method to reduce dose heterogeneity when treating with 
three fields (two beam energies) abutted off-axis while minimizing dose in the central 
region beyond the distal target surface.  This target might approximate a PTV around the 
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spinal cord, e.g. for treatment of the paraspinal muscles for mesenchymal 
chondrosarcoma.       
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Figure 24:  Illustration of the pentagon target.  The dashed line represents 
the phantom surface. 
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Figure 25:  Illustration of the inverted well target.  The dashed line 
represents the phantom surface. 
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2.4.2  Treatment Planning 
The 1D energy segmentation plans for treatment of the simple PTVs using the 
variable-SCD method were designed with the following goals: 
1.  Conform the 90% isodose contour to the PTV. 
2.  Minimize dose heterogeneity in the target, i.e. maximum dose < 105% and 
minimum dose > 85%  
 To accomplish the first goal, beam energies required to treat a particular portion 
of the target volume were selected based on the R90 depths of a 10x10-cm2 field size.  
Blocks were then created for each beam in order of highest energy to lowest.  To account 
for the fact that the beam edge locates the 50% dose point at the R100 depth, each field 
edge is extended beyond its target volume by a lateral margin of at least 0.5*P90-10 @ 
R100, with higher energies taking territorial precedence over lower energies.   
After defining all beam edges and calculating dose for each beam, the following 
beam weight procedures were followed with the goal of minimizing dose heterogeneity:    
1.  A single beam is weighted 100%, i.e. all other beams are weighted to 0%. 
2.  A normalization point is chosen for that beam such that the maximum dose is 
100%. 
3.  Monitor units are assigned to the beam so that dose to the normalization point 
is approximately 50 cGy.  
4.  Steps 1 to 3 are repeated until a normalization point is assigned to each beam. 
5.  All beams are weighted by the monitor units determined in steps 1-4 giving a 
composite dose distribution.  
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6.  The absolute dose at each normalization point from step 2 is checked.  If the 
dose to all normalization points is greater than 51 cGy (102%), monitor units are 
reduced for all beams uniformly (scaled) such that the dose to at least one 
normalization point is approximately 50 cGy.       
7.  The composite dose distribution is normalized to 100% at a selected 
normalization point with an absolute dose of approximately 50 cGy.     
8.  Monitor units are adjusted for an individual beam if (1) dose to the target 
volume is >105% and the modification does not result in diminished target 
coverage or (2) target coverage can be improved without violating the 
heterogeneity goals.   
2.4.3  Plan Evaluation and Comparisons 
 Dose distributions in the PTV and the "outside PTV' ROIs for the standard 
applicator and variable-SCD applicator plans were compared quantitatively based on the 
maximum and minimum dose, dose spread (maximum - minimum), mean dose, and σ 
(standard deviation) of the dose distribution.  Additionally, D90-10 was used to compare 
dose homogeneity in the PTVs.  D90-10 is defined as the difference between the dose 
received by 90% of the PTV volume and the dose received by 10% of the PTV volume, 
which was determined using cumulative dose volume histograms (DVHs).      
2.5  Aim 4B:  Evaluate Dose Homogeneity in Patient PTV  
The potential for the variable-SCD method to improve dose homogeneity in a 
heterogeneous target was assessed by studying a single patient case.  A plan was 
designed such that the 90% isodose surface covers the PTV with dose homogeneity 
comparable to treatment with a single square field. 
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2.5.1  Patient Treatment Planning 
2.5.1.1  Treatment Planning Objectives 
 The goals of the patient treatment plan developed using the variable-SCD method 
were as follows: 
 1.  Conform the 90% isodose contour to the PTV. 
 2.  Minimize dose to all critical structures. 
3.  Minimize dose heterogeneity in the target, especially in the abutment region of 
adjacent beams  
2.5.1.2  Segmented-field ECT Treatment Planning 
 Prior to beginning the segmented-field ECT treatment planning methods outlined 
in this section, initial setup parameters common to all fields (i.e. gantry angle, couch 
position, and SSD) were selected.  These parameters are ideally specified such that (1) 
the patient or bolus surface is located at isocenter (100-cm SSD), (2) beam central-axis 
intersects approximately the center of the PTV, and (3) the distance from the surface to 
the maximum PTV depth along the direction of beam central-axis is minimized.    
To create an acceptable treatment plan using segmented-field electron conformal 
therapy, it was necessary to determine the minimum beam energy needed to treat the 
maximum depth of each portion of the PTV.  Segmented fields were then defined with 
appropriate margins to insure good coverage.  A field segmentation and energy 
modulation method developed by Rogers (2005) was modified for the present aim.          
• PTV Segmentation 
 PTV segmentation is done to aid the planner in choosing the appropriate beam 
energies to treat subsets of the PTV.  PTV segmentation was based on the distal R90 
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values of fields having side scatter equilibrium for the electron beam energies available 
with the 2100EX 6/18 radiotherapy accelerator.  Table 3 lists R90 values for a 10x10-cm2 
field size for each beam energy.   
 
Table 3:  Summary of beam parameters used for treatment planning.  All 
values were obtained using TPS data for a 10x10-cm2 field size at 100-cm 
SSD with modified air gaps (5, 7.5, 11.5, 17.5, and 19.5 cm).   
Treatment planning beam data reference for 10x10-cm2 field 
Distance (cm) 6 MeV 9 MeV 12 MeV 16 MeV 20 MeV 
R100 1.5 2.0 2.9 3.0 1.9 
R90  1.9 2.6 3.9 5.1 5.9 
(P90-10)/2 at R100 0.8 0.85 1.1 1.2 0.8 
 
The following steps outline the PTV segmentation procedure used to create volume 
contours (notated as the energy followed by "V"). 
1.  The skin surface (or bolus surface if present) is contoured for all slices 
containing the PTV.  The resulting contour is defined "Surface" (Figure 26b). 
2.  The surface contour is contracted for each beam energy to be used by its 
corresponding R90 value (Table 3).  The resulting contours are defined 20T, 16T, 
12T, 9T, and 6T ("T" for temporary) (cf. Figure 26c).  
3.  Contour 6V is created as a copy of the PTV with the 6T volume excluded. 
4.  Contour 9V is created as a copy of the PTV with the 6V and 9T volumes 
excluded. 
5.  Contour 12V is created as a copy of the PTV with the 6V, 9V, and 12T 
volumes excluded. 
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6.  Contour 16V is created as a copy of the PTV with the 6V, 9V, 12V and 16T 
volumes excluded. 
7.  Contour 20V is created as a copy of the PTV with the 6V, 9V, 12V, 16V and 
20T volumes excluded. 
(Note:  Steps 3-7 are accomplished in Pinnacle3 by expanding the PTV contour by 
0-cm with the contours to be excluded set as limiting structures.) 
The resulting 6V, 9V, 12V, 16V, and 20V contours (Figure 26d) contain the PTV 
volume that can be treated by that energy.  These contours can be displayed one at a time 
in the beams-eye view (BEV) window. 
 
Figure 26:  Single transverse slice illustrating the PTV segmentation 
method for a patient case planned using 1 cm of bolus.  The white dotted 
line indicates beam direction.  Note:  All contours are shown in color wash 
except the PTV which is shown in outline.  (a) Lavender PTV contour,  (b) 
orange surface contour,  (c) contours 6T (green),  9T (blue), 12T (red), and 
16T( (yellow),  (d)  contours 6V (green),  9V (blue), 12V (red), and 16V 
(yellow).         
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• BEV Depth Map 
 The contours created by PTV segmentation were used to create additional 
contours that can be viewed simultaneously in the BEV window as a depth map (Figure 
27).  The following steps detail how this was done: 
1.  Expand the highest energy "V" contour that contains the PTV by R90 + 0.2 cm 
toward the skin and parallel to the beam central-axis with no limiting structures.  
If the beam direction is not parallel to one of the orthogonal axes, vector 
components can be used to specify the direction of expansion.  The resulting 
contour should extend beyond the skin surface slightly and is defined "E MAP" 
where E is the beam energy. 
2.  Expand the next lowest energy "V" contour by R90 + 0.2 cm toward the skin 
and parallel to the beam central-axis with the previous energy MAP contour as a 
limiting structure.  The resulting contour should extend beyond the skin surface 
slightly but should not extend beyond the previous energy's MAP contour. 
3.  Repeat step 2 for the remaining energies, each time using all previously 
created MAP contours as limiting structures.  
• Segmented-field Energy Modulation 
 The volume contours described in the PTV segmentation portion of this aim are 
used to create energy-segmented fields.  It is also possible to manually draw the desired 
fields using the BEV depth map.   
 To aid in applying appropriate beam margins it is useful to create a "PTV plus 
margin" contour (PTVPM).  The PTVPM (Figure 28) extends the PTV in all directions 
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perpendicular to the beam by the desired margin (usually 1 - 1.5 cm) so that the planner 
can allow for dose falloff around the perimeter of the target volume (Rogers 2005). 
 
Figure 27:  Example of BEV depth map.  (a) Transverse view of contours 
6 MAP (green),  9 MAP (blue), 12 MAP (red), and 16 MAP (yellow).  (b)  
MAP contours from the beams-eye view.     
 
 
Figure 28:  Beams eye view of PTVPM (green wire frame) generated by 
expanding the PTV (solid blue) by 1 cm in all directions. 
  
 45
The following steps detail the method used to create segmented energy fields using the 
volume contours: 
1.  The first beam is added to the beam list and given the desired setup geometry, 
i.e. the planner selects the beam direction and the applicator to be used based on 
their best judgment.  This beam is set to the highest energy to be used. 
2.  A block is added in the beam modifier list and the blocking mode is set to 
"expose" the appropriate "V" contour with a minimum margin of (P90-10)/2 at R100 
for that beam energy (cf. Table 3).  The block mode is then changed from auto-
block to manual allowing the planner to modify the block shape.  At this point the 
block may be expanded to a) include small patches that may be nearby but 
separate from the larger exposed portions or b) expand the block to expose the 
PTVPM if the distance from the block edge to the PTVPM edge is on the order of 
1 cm (this eliminates unnecessary decreases in energy in these areas, allowing the 
natural dose falloff to follow the tapering in depth of the PTV).     
3.  The next highest energy beam is created using the TPS "copy beam" function, 
which generates an identical copy of the previous beam with its blocks.  The 
block used to expose the target for the previous beam is now set to "block" (this 
ensures field edges coincide) and the energy is reduced to the next highest energy.     
4.  Steps 2 and 3 are repeated until all beams have been defined. 
Often blocks are created with two or more separated apertures or with block 
regions that are not connected to the outer perimeter of the block.  In these cases the TPS 
will not calculate dose.  Procedures for dealing with these circumstances are described 
below: 
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1)  If a beam has two or more separate exposure regions that are 2x2 cm2 or 
larger, the beam is copied and each exposure region is assigned to a separate 
beam.    
2)  If a separate exposure region is smaller than 2x2 cm2, it is connected to the 
nearest exposure region using the brush function in the BEV.  When this method 
is used, the connector region is added when the beam is initially created.  This 
allows the "beam copy" segmentation method to account for the connector region,  
avoiding overlaps.  
3)  If one or more block regions are not connected with the perimeter of the block, 
the beam is copied and the block is divided between the two beams such that the 
common edge intersects the disconnected area(s).  This is done after the "beam 
copy" segmentation method is complete.   
• Segmented-field Modification 
 When applied to a patient case, the methods described above can still result in 
poor target coverage.  This is most commonly due to the presence of a curved or 
otherwise irregular patient surface.  In the presence of a sloped surface dose tends to 
extend beyond the beam edge due to disproportionate scatter into the region.  To account 
for this, beam edges along the perimeter of the target are adjusted to reduce the field size.  
The presence of thick regions of bone in the target can also result in poor coverage as 
decreased penetration in bone has not been taken into account.  In these cases, beam 
energy is increased if possible. 
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2.5.2  Patient Case 
A segmented-field treatment plan was developed for a patient case to compare the 
standard and variable-SCD applicator methods.  The case was chosen with assistance 
from a radiation oncologist to reflect a typical PTV that could be treated with electron 
conformal therapy, e.g. custom bolus or segmented-field electron therapy.   
The patient selected for this study had recurrent squamous cell carcinoma of the 
left ear and had undergone a total auriculectomy with parotidectomy and upper neck 
dissection before receiving post-operational radiation therapy.  A dose of 50 Gy was 
delivered in 25 fractions to the ear area and neck using 4 MV photons, and to the left 
scalp using 9 MeV electrons.  The radiation oncologist contoured the PTV covering 62 3-
mm CT slices.  The PTV extends from the skin surface to a minimum depth of 1 cm and 
a maximum depth of 3.2 cm.  The left lacrimal gland, left eye, left optic nerve and the 
spinal cord were also contoured by the radiation oncologist as dose limiting structures. 
Because the PTV extended to the skin surface, a 1-cm bolus contour was drawn 
on the patient surface.  Using the "density override" function, the contoured volume was 
given a density of 1 g cm-3.  The procedures described in the previous section were 
carried out with the bolus surface at isocenter, the gantry at 90°, and the couch at 180°, 
resulting in the volume contours and depth map in Figures 26 and 27 respectively.  To 
reduce plan complexity (i.e. the number of fields used), the 6V contour was combined 
with the 9V contour.  To reduce the dose to the eye and lacrimal gland, the gantry angle 
was increased to 110° (Figure 29) and a 1-cm lead eye shield was contoured over the eye 
in 7 transverse slices (2.1 cm) and extended over 5 slices (1.5 cm) in both the superior 
and inferior directions.  
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The 9, 12, 16, and 20 MeV beams in Figure 30 were defined using the segmented-
field energy modulation procedures described in the previous section.  A beam weight of 
19.87% (212 MU) was assigned to the 9 MeV beam and the two 12 MeV beams, 20.71% 
(221 MU) to the 16 MeV beam, and 19.68% (210 MU) to the 20 MeV beam.   
 
Figure 29:  Room's-eye view of treatment setup with the gantry at 110°, 
the table at 180°, and the SSD at 100 cm.    
 
 
 
Figure 30:  Sagittal view of the 9, 12, 16, and 20 MeV beams projected at 
a depth of 2 cm in the patient.      
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Chapter 3   
Results and Discussion 
 
3.1  Aim 1:  Design of Methods for Matching Penumbra 
 
The air gaps to be used in the implementation of the variable-SCD method were 
selected to reduce dose heterogeneity for any combination of beam energies based on 
inspection of penumbra width calculations (in water) as a function of air gap.  Figures 31, 
32, and 33 plot the results of these calculations for all energies at 1.5 cm, 2 cm, and 2.5-
cm depth, respectively.  The points connected by the dotted lines represent the air gaps 
selected for each energy.  The air gaps were selected from the available insert tray 
positions (7.5-19.5 cm in 2 cm increments) so that P80-20 penumbra widths were 
approximately equal for all beam energies at a depth of 1.5 cm in water for 100-cm SSD. 
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Figure 31:  P80-20 calculated in water as a function of air gap at 1.5-cm 
depth.    
 
 50
Air gap (cm)
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
P
80
-2
0
0.0
0.5
1.0
1.5
2.0
2.5
3.0
 6 MeV
9 MeV
12 MeV
16 MeV
20 MeV
 
Figure 32:  P80-20 calculated in water as a function of air gap at 2-cm depth.    
 
igure 33:  P80-20 calculated in water as a function of air gap at 2.5-cm 
th 
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F
depth.  The 6 MeV penumbra width is not connected as central-axis dep
dose is less than 50% at this depth.       
 51
The lowest energy, 6 MeV, has the broadest penumbra and was therefore assigned 
the standard 5-cm air gap.  The 20 MeV beam has the sharpest penumbra and was 
assigned the largest air gap available using the variable-SCD applicator (19.5 cm).  To 
approximately match the 6, 9, and 12 MeV at 1.5 cm, air gaps of 7.5 cm and 11.5 cm 
were assigned to 9 MeV and 12 MeV respectively.  A 17.5-cm air gap was assigned to 16 
MeV so that the 12, 16, and 20 MeV penumbras are approximately matched at 2 and 2.5 
cm while maintaining decent abutment dosimetry between 9 MeV and 16 MeV.  
Comparing penumbra width plotted as a function of depth using the standard air gap 
(Figure 34) and the selected variable-SCD air gaps (cf. Figure 35), one sees that the latter 
achieves improved penumbra agreement, particularly from 1 to 2-cm depth.       
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Figure 34:  Plot of theoretical P80-20 (calculated in water) as a function of 
depth from 0 cm to ~R80 (maximum therapeutic range) for all beam 
energies using the standard 5-cm air gap.  
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Figure 35:  Plot of theoretical P80-20 (calculated in water) as a function of 
depth from 0 cm to ~R80 (maximum therapeutic range) for all beam 
energies using the variable-SCD air gaps.   
 
3.2  Aim 2: Verification of Electron Beam Commissioning in TPS 
 
 The ability of the commissioned electron pencil beam algorithm to accurately 
predict dose to a phantom was assessed by comparing calculated and measured 2D dose 
distributions for 4x4-cm2 and 15x15-cm2 fields at 100-cm SSD.  Previously 
commissioned beam data were verified by doing the comparison for the standard 
applicator.  Commissioned beam data with modified parameters (energy-specific air gaps 
and modified 
xθσ ) for the variable-SCD applicator were verified similarly.   
Comparisons of central-axis depth dose and off-axis profiles were performed 
using central xz-plane isodose plots normalized to 100% of the central-axis maximum 
dose.  Because the variable-SCD method requires an air gap of 5 cm be used for the 6 
MeV beam, dose distribution comparisons were performed for 6 MeV using the standard 
15x15-cm2 applicator.  Because segmented-field ECT will often necessitate the use of 
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small fields and rarely the use of large open fields, measured and calculated dose 
distributions for 6, 9, 12, 16, and 20 MeV are presented in the text for a 4x4-cm2 field 
size.  The results of comparisons for 15x15-cm2 fields are presented in Appendix B. 
3.2.1   6 MeV 
Figure 36 shows the comparison of measured and calculated dose distributions for 
a 6-MeV, 4x4-cm2 field using the standard air gap.  Good agreement (< 1-mm distance to 
agreement (DTA)) is seen in field size (defined by the 50% isodose contour) as well as 
central-axis depth dose for depths greater than 0.5 cm.  In the region of therapeutic dose, 
the 80% isodose contours agree within 1-mm DTA, while the measured data for dose 
points greater than 90% are less than calculated dose by as much as 5% (1.5-cm depth 
and -1-cm off-axis).  For dose less than 5%, the calculated dose underestimates the 
measured dose by as much as 5% between 1 to 2-cm depth, and overestimates the 
measured dose by as much a 5% for depth greater than 2 cm (i.e. corners of the dose 
falloff region).  Results for the 15x15-cm2 field size (cf. Figure B1) are similar to the 
4x4-cm2 field size results.               
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Figure 36:  6 MeV central xz plane measured (solid line) and calculated 
(dashed line) isodose plots for a 4x4-cm2 field using the standard 
applicator (5-cm air gap).  
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3.2.2  9 MeV 
Figure 37 shows isodose plots of measured and calculated dose distributions 
overlaid for a 9 MeV, 4x4-cm2 field using the standard applicator (5-cm air gap) and the 
variable-SCD applicator (7.5-cm air gap).  In both cases, agreement is within 1-mm DTA 
on central-axis depth dose, as well as for off-axis dose > 30%.   
The influence of the increased air gap in the penumbra region is evidenced by the 
distance from the measured 90% to 10% isodose lines at 1.5-cm depth increasing from 
1.3 cm for the standard applicator dose distribution to 1.6 cm for the variable-SCD 
applicator dose distribution.        
Results for the 15x15-cm2 field size (cf. Figure B2 and B3) are similar to the 4x4-
cm2 field size results.  However, a notable difference for both applicators is seen between 
±5-cm and ±7.5-cm off-axis from 1.5-cm to 2-cm depth, where calculated dose 
overestimates measured dose by as much as 5%.  This is likely due to sub-optimal off-
axis ratios being used for calculation.           
3.2.3  12 MeV 
 
Figure 38 shows isodose plots of measured and calculated dose distributions 
overlaid for a 12 MeV, 4x4-cm2 field using the standard applicator (5-cm air gap) and the 
variable-SCD applicator (11.5-cm air gap).  In both cases, agreement is within 1-mm on 
central-axis depth dose beyond 3.5 cm, as well as off-axis dose for dose ≥ 30%.  From 1 
cm to 3.5 cm in depth, and ±2 cm off-axis (a low dose gradient region), agreement in 
percent dose is within 2%.   
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Figure 37:  9 MeV central xz plane measured (solid line) and calculated  
(dashed line) isodose plots for a 4x4-cm2 field using (a) the standard 
applicator (5-cm air gap) and (b) the variable-SCD applicator (7.5-cm air 
gap). (figure continued) 
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Figure 38:  12 MeV central xz plane measured (solid line) and calculated 
(dashed line) isodose plots for a 4x4-cm2 field using (a) the standard 
applicator (5-cm air gap) and (b) the variable-SCD applicator (11.5-cm air 
gap). 
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The influence of the increased air gap is evidenced by the distance from the 
measured 90% to 10% isodose lines at 2-cm depth increasing from 1.2 cm for the 
standard applicator to 1.7 cm for the variable-SCD applicator.       
Results for the 15x15-cm2 field size (cf. Figure B4 and B5) are similar to the 4x4-
cm2 field size results.  However, a notable difference for the standard applicators is seen 
between ±5-cm and ±7.5-cm off-axis from 1.5-cm to 3.5-cm depth, where calculated dose 
overestimates measured dose by as much as 5%.  Interestingly, this discrepancy is not 
seen in the variable-SCD applicator results for the 15x15-cm2 field size.                 
3.2.4  16 MeV 
Figure 39 shows isodose plots of measured and calculated dose distributions 
overlaid for a 16 MeV, 4x4-cm2 field using the standard applicator (5-cm air gap) and the 
variable-SCD applicator (17.5-cm air gap).  Agreement is within 1-mm DTA on central-
axis depth dose in the standard applicator distribution for depths from 3.5 cm to 8 cm.  
Similar agreement is seen in the variable-SCD applicator distribution, with the exception 
of 3.5 to 5 cm in depth, where DTA is as much as 2 mm.  In both cases, from 1.5 cm to 
3.5 cm in depth, and within ±2 cm off-axis (a low dose gradient region), agreement is 
within 2% and agreement in lateral dose falloff for doses ≥ 30% is within 1 mm.   
The large disparity seen in the 5% isodose contour of the standard applicator 
distribution is likely due to low energy electrons generated in the block by photons in the 
beam.  As a result of the difference in distance between the Cerrobend block and the 
phantom surface for standard and variable-SCD applicators, low energy electrons 
escaping the distal surface of the block have a less pronounced effect in the latter case.     
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Figure 39:  16 MeV central xz plane measured (solid line) and calculated 
(dashed line) isodose plots for a 4x4-cm2 field using (a) the standard 
applicator (5-cm air gap) and (b) the variable-SCD applicator (17.5-cm air 
gap). 
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The influence of the 12.5 cm increase in air gap is evidenced by the distance from 
the measured 90% to 10% isodose lines at 2-cm depth increasing from 1.1 cm for the 
standard applicator distribution to 1.8 cm for the variable-SCD applicator distribution.       
Results for the 15x15-cm2 field size (cf. Figure B6 and B7) are generally similar 
to the 4x4-cm2 field size results.  As in the case of the 12 MeV beam results, a notable 
difference for the standard applicators is seen between ±5-cm and ±7.5-cm off-axis from 
1.5-cm to 3.5-cm depth, where calculated dose overestimates measured dose by as much 
as 5%.  Again, this is likely due to sub-optimal off-axis ratios being used for calculation.  
Additionally, for the variable-SCD applicator results for the 15x15-cm2 field size, a 
significant difference is seen in depth dose from 1-cm to 2-cm, where calculated dose 
overestimated measured dose by as much as 5%.  This is likely due to less electrons 
scatter from the collimator reaching the phantom surface as a result of the increased air 
gap.                      
3.2.5  20 MeV 
Figure 40 shows isodose plots of measured and calculated dose distributions 
overlaid for a 20 MeV, 4x4-cm2 field using the standard applicator (5-cm air gap) and the 
variable-SCD applicator (19.5-cm air gap).  In both cases, central-axis depth dose DTA is 
within 2 mm from 5.5 cm to 8 cm depth, but increases to as much as 3.5 mm from 8 cm 
to 10 cm depth.  In contrast, good agreement in lateral dose falloff from 1.5 cm to 4 cm 
depth for doses between 30% and 80% indicates good field size agreement.  The source 
of the CAX depth dose discrepancy is not clear, but it should be noted that measured 
distributions for larger field sizes do not exhibit this incongruity (cf. Figures B8 and B9).   
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Figure 40:  20 MeV central xz plane measured (solid line) and calculated 
(dashed line) isodose plots for a 4x4-cm2 field using (a) the standard 
applicator (5-cm air gap) and (b) the variable-SCD applicator (19.5-cm air 
gap). 
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As in the case of the 16 MeV distributions, the large disparity seen in the 5% 
isodose contour of the standard applicator distribution is likely due to low energy 
electrons generated in the block by photons in the beam.  In this case, however, the effect 
is more pronounced as more electrons with sufficient energy to escape the block are 
generated using the 20 MeV beam.  
The influence of the 14.5 cm increase in air gap is evidenced by the increase in 
off-axis distance between the measured 90% and 10% isodose lines from 1.1 cm for the 
standard applicator to 1.6 cm for the variable-SCD applicator at 2-cm depth.   
Results for the 15x15-cm2 field size (cf. Figure B8 and B9) are similar to the 4x4-
cm2 field size results with the exception of the differences in depth dose noted above.  
Also, as in the case of the 16 MeV beam results, a notable difference for the standard 
applicators is seen between ±5-cm and ±7.5-cm off-axis from 1.5-cm to 3-cm depth, 
where calculated dose overestimates measured dose by as much as 5%.   
3.3  Aim 3:  Construction of Cerrobend® Blocks with Diverging Edges 
 
The accuracy of the beam collimation method (i.e. construction of Cerrobend 
inserts using the Compu●cutter® system and insert placement) was evaluated for the 
variable-SCD applicator by comparing off-axis dose profiles for a single square field to 
that of two equally-weighted, abutted fields for each of the three tests in this section.  
Results for a 12 MeV beam (SCD = 78.5 cm) are shown. 
3.3.1  Accuracy and Precision of Off-axis Abutment Test  
 
Figures 41 (a-c) compare the off-axis profile at 1-cm depth of a single 12 MeV 
field (12x12-cm2) with three abutment trials consisting of two 12 MeV fields (3.5x12-
cm2 and 8.5x12-cm2) abutted 2.5 cm off-axis.  In trial 1 (Figure 41a) a dose deficiency of  
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Figure 41:  2.5-cm off-axis abutment tests comparing measured off-axis 
profiles at 1-cm depth for two 12 MeV fields (3.5x12 cm2 and 8.5x12 cm2) 
abutted at 2.5 cm off-axis (solid line) and a single 12 MeV field (12x12-
cm2) (dashed line).  The arrows indicate the abutment region.  (a) Trial 1, 
(b) Trial 2, (c) Trial 3.   
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-1.46% is seen at 2.5-cm off-axis corresponding to Δx = -0.17 mm.  In trial 2 (Figure 
41b) a dose deficiency of -1.8% is seen at 2.5-cm off-axis, corresponding to Δx = -0.21 
mm.  In trial 3 (Figure 41c) a dose deficiency of -5.5% at 2.5-cm off-axis is seen 
corresponding to Δx  = -0.65 mm. 
The results of the three trials, summarized in table 4, show that there was a 
sample mean dose error (ΔD ) of -2.9 ± 1.3% and a sample standard deviation (σΔD) of 
2.2%.  Based on calculated ΔD/Δx of 8.5%/mm, this ΔD  implies an accuracy (systematic 
error) in edge fabrication and alignment of Δx  = -0.30 ± 0.15 mm.  Additionally, σΔD = 
2.2% implies a precision (random error) in fabrication and alignment of σΔx = 0.27 mm.   
 
Table 4:  Summary of results of 2.5-cm off-axis abutment test. 
# meas DΔ± σΔD  (%) DΔσ  (%) xΔ± σΔx  (mm) xΔσ (mm) 
3 -2.9 ± 1.3 2.2 -0.30 ± 0.15 0.27 
 
 
3.3.2   Zero and 5-cm Off-axis Abutment Test 
   
The abutment tests made at xint = +2.5 cm were repeated using a single film 
measurement for xint = 0 cm (central-axis) and for xint = 5 cm.  The measured values for 
ΔD were +1.2 and -4.2 respectively, which gave values for Δx of 0.14 mm and -0.49 mm.  
Hence, abutment accuracy at 0, +2.5, and +5.0 cm off-axis were +0.14 ± 0.27 mm, -0.34 
± 0.15 mm, and -0.49 ± 0.27 mm, respectively.  These results indicate a slight correlation 
of Δx with off-axis location (Δx ≈ -0.01 × off-axis location). 
3.3.3  Test of Dosimetric Impact of Errors in Block Fabrication 
 
The impact of error in block edge fabrication and alignment is illustrated in 
Figure 42, which plots off-axis profiles measured for the intentional block abutment  
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Figure 42:  Dosimetric impact of errors in block fabrication. Two 12 MeV 
beams (6x12 cm2 and 6x12 cm2) abutted on central-axis (xint = 0) with 
errors introduced in edge placement (solid line) are compared with a 
single 12x12-cm2 field (dashed line).  (a) Δx = -4 mm resulting in ΔD of -
35.8%, (b) Δx = -2 mm resulting in ΔD of -18.3%, (c) Δx = 0 mm 
resulting in ΔD of +1.2%, (d) Δx = +2 mm resulting in ΔD of +14.6%, and 
(e) Δx = +4 mm resulting in ΔD of +34.1%.   
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errors of Δx = -4, -2, 0, +1, and +4 mm.  Resulting values of ΔD were -35.8%, -18.3%, 
+1.2%, +14.6%, and +34.1%, respectively.   
Assuming an uncertainty of 2.2% (determined in previous data), Figure 43 plots 
ΔD versus Δx.  These data are consistent ( = 0.64 and p = 0.6) with the theoretical line, 
which corresponds to 8.5%/mm, determined for the 12 MeV beam.   
2
υχ
Based on these results, random error in block edge fabrication and alignment (σΔx 
= 0.27 mm) should be less than 0.54 mm (2σ).  This results in a 95% confidence interval 
for ΔD of 4.6% (0.54 mm x 8.5%/mm). 
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Figure 43:  Measured dosimetric impact of errors in beam edge placement 
plotted with the calculated line with 8.5%/mm slope.  Results are plotted 
as measured ΔD vs. intended Δx.  Error bars represent σΔD = 2.2% 
determined in the 2.5-cm off-axis abutment test.    
 
3.4  Aim 4a:  Evaluate Dose Homogeneity in Simple Targets  
 
This section presents the results of studying the utilization of the variable-SCD 
applicator for segmented-field conformal therapy for four idealized PTVs.  The first set 
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of results for each PTV compares a treatment plan using the variable-SCD applicator to 
that using the standard applicator.  The second set of results compares dose measurement 
of the variable-SCD plan delivered to a phantom to the calculated dose distribution for 
each PTV. 
3.4.1  Treatment Planning Results 
3.4.1.1  Two-step Block Target 
This target was divided into two regions, region 1 (negative off-axis position) 
having a distal target depth of 2.5 cm and region 2 (positive off-axis position) having a 
distal target depth of 4 cm.  A 9 MeV beam (R90 = 2.6 cm) was selected to irradiate 
region 1 and a 16 MeV beam (R90 = 5.1 cm) to irradiate region 2.  Beam edges were 
defined to account for lateral falloff by placing the edges of the 16 MeV beam 1 cm 
beyond the inner boundary of region 2 and 1.3 cm beyond the outer boundary.  The 9 
MeV beam was then defined with its inner edge at the same position as the 16 MeV 
beam's inner edge and the outer edge 1.3 cm beyond the outer boundary of region 1.  The 
16 MeV beam normalization point (+1.6 cm off-axis, 3 cm depth) was chosen as the 
reference dose point for the composite distribution, allowing an increase from 48 to 49 
MU for the 9 MeV beam to pull the 90% isodose surface toward the surface, resulting in 
better PTV coverage.  A beam weight of 49 MU (49.5%) was assigned to the 9 MeV 
beam and a weight of 50 MU (50.5%) to the 16 MeV beam.   
Treatment planning dose distributions using the standard and variable-SCD 
applicators are presented as isodose plots in Figures 44a and 44b, respectively.  The 
DVHs for both trials are overlaid in Figure 45, and the DVH statistics are summarized in 
Table 5.   
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Figure 44:  Isodose plots of TPS calculated dose distributions for 
irradiation of the two-step block target in a polystyrene phantom for (a) 
the standard applicator plan and (b) the variable-SCD applicator plan.   
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Figure 45:  Cumulative DVHs for the two-step block target showing PTV 
and Outside PTV ROIs.  The standard trial is represented by dotted lines 
and the variable-SCD trial by solid lines. 
 
 
Table 5:  Summary of treatment planning results for irradiation of the two-
step block target using the standard and variable-SCD methods.  
Two-step block target 
Trial ROI 
Mean 
Dose 
(%) 
σ 
(%) 
Min 
(%) 
Max 
(%) 
D90-10
(%) 
Standard PTV 97.6 4.2 78.0 108.5 10.3 
Variable-SCD PTV 97.2 3.2 85.8 102.8 7.7 
Standard Outside PTV 44.0 33.9 3.8 108.3  
Variable-SCD Outside PTV 43.9 32.6 3.8 102.8  
 
The variable-SCD applicator plan in Figure 44b provides a visibly more uniform 
dose distribution than the standard applicator plan in Figure 44a.  This is reflected in the 
variable-SCD applicator plan's significantly steeper DVH, 24% reduction in σ, and 25%  
reduction in D90-10 for the PTV.  The unmatched penumbra in the standard applicator plan 
results in a cold spot in the PTV as low as 78% and a hot spot as great as 109%.  There 
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remains in the variable-SCD applicator plan (1) a small cold spot of 86% (0.7 cm depth, -
0.8 cm off-axis) due to the 16 MeV penumbra being greater than the 9 MeV penumbra at 
depths less than 1.5 cm (cf. Figure 35), and (2) a small hot spot of 103% (2 cm depth,      
-3.6 cm off-axis) due to 49 rather than 48 MU having been assigned to the 9 MeV beam 
in order to contain the proximal target surface in the 90% isodose contour. 
Due to the location of the abutment edge, the hot spot in the standard applicator 
plan that results from unmatched penumbra is located partially outside the PTV.  
Therefore, the penumbra matching in the variable-SCD plan results in a 5% reduction in 
dose spread outside the target and a 4% reduction in σ.  As expected however, the 
difference in mean doses outside the target is less than 0.5%.  
3.4.1.2  Wedge Target 
This target was divided into three regions, region 1 (negative off-axis position) 
having a distal target depth range of 5.5 cm to 4.6 cm, region 2 (about central-axis) 
having a distal target depth range of 4.6 cm to 3.7 cm, and region 3 (positive off-axis 
position) having a distal target depth range of 3.7 cm to 2.7 cm.  A 20 MeV beam (R90 = 
5.9 cm) was selected to treat region 1, a 16 MeV beam (R90 = 5.1 cm) to treat region 2, 
and a 12 MeV beam (R90 = 3.9 cm) to treat region 3.  The 20 MeV beam was defined 
with the inner edge at -1.5 cm and the outer edge placed 2.5 cm beyond the outer 
boundary of region 1 at -7.5 cm to obtain good target coverage.  Beam edges for the 16 
MeV beam (region 2) were defined at ±1.5 cm off-axis.  The 12 MeV beam was then 
defined with the inner edge at +1.5 cm to match the 16 MeV field, and the outer edge 
placed 1.5 cm beyond the outer boundary of region 3.  The 12 MeV beam normalization 
point (+4 cm off-axis, 3 cm depth) was chosen as the reference point for the composite  
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Figure 46:  Isodose plots of TPS calculated dose distributions for 
irradiation of the wedge target in the polystyrene phantom for (a) the 
standard applicator plan and (b) the variable-SCD applicator plan.  
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Figure 47:  Cumulative DVHs for the wedge block target showing PTV 
and Outside PTV ROIs.  The standard trial is represented by dotted lines 
and the variable-SCD trial by solid lines. 
 
 
Table 6:  Summary of treatment planning results for irradiation of the 
wedge target using the standard and variable-SCD methods.  
Wedge target 
Trial ROI 
Mean 
Dose 
(%) 
σ 
(%) 
Min 
(%) 
Max 
(%) 
D90-10
(%) 
Standard PTV 97.6 2.8 88.9 104.2 7.4 
Variable-SCD PTV 97.6 2.4 89.2 102.6 6.1 
Standard Outside PTV 56.1 32.0 5.7 100.6  
Variable-SCD Outside PTV 56.2 31.4 5.7 101.2  
 
dose distribution.  A beam weight of 48 MU (34%) was assigned to the 20 MeV beam, 46 
MU (32.6%) to the 16 MeV beam, and 47MU (33.3%) to the 12 MeV beam. 
Treatment planning dose distributions using the standard and variable-SCD 
applicators are presented in Figures 46a and 46b respectively.  The DVH for both trials 
are overlaid in Figure 47 and the DVH statistics are summarized in Table 6.  Because the 
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abutted fields have adjacent energies, the variable-SCD plan in Figure 46b provides only 
a moderate improvement in dose homogeneity over the standard applicator plan in Figure 
46a.  The penumbra matching of the variable-SCD applicator provided a 1.5% reduction 
in maximum dose to the PTV as compared to the standard applicator plan, and less than a 
1% increase in minimum dose.  This is reflected in a 14% reduction in σ and a 18% 
reduction in D90-10 for the PTV DVH.  Also, less than 2% reduction is seen in the σ of the 
dose outside the PTV and less than 1% reduction in dose spread.   
3.4.1.3  Pentagon Target 
 
This target was divided into three regions, region 1 (negative off-axis position) 
and region 3 (positive off-axis position) having minimum distal target depths of 2.5 cm, 
and region 2 (about central-axis) having a maximum distal target depth of 5.5 cm.  A 12 
MeV beam (R90 = 3.9 cm) was selected to treat regions 1 and 2, and a 20 MeV beam (R90 
= 5.9 cm) to treat region 2.  Beam edges were defined for the center 20 MeV beam 
(region 2) at ±3.5 cm off-axis.  The 12 MeV beams for regions 1 and 3 were then defined 
with inner edges at ±3.5 cm to match the 20 MeV field, and the outer edges placed 1 cm 
beyond the outer boundaries of the target at ±6 cm off-axis.  The central 20 MeV beam 
normalization point (0 cm off-axis, 2.2 cm depth) was chosen as the reference point for 
the composite dose distribution.  A beam weight of 49 MU (49.5%) was assigned to the 
20 MeV beam and 50 MU (50.5%) to the 12 MeV beams. 
The two 12 MeV fields for this case were defined using a single block.  Because 
Pinnacle3 does not calculate dose for non-contiguous block definitions, a 3-mm wide 
"connector region" was included in the block definition (located well outside the 
transverse plan containing the PTV).   
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Treatment planning dose distributions using the standard and variable-SCD 
applicators are presented in Figure 48a and 48b, respectively.  The DVHs for both trials 
are overlaid in Figure 49, and the DVH statistics are summarized in Table 7.   
 The variable-SCD applicator plan in Figure 48b provides a significantly more 
uniform dose distribution than the standard applicator plan in Figure 48a.  For the PTV, a 
39% reduction in σ, 34% reduction in D90-10, and a 32% reduction in dose spread are 
seen, all of which are reflected in the sharper target DVH of the variable-SCD applicator 
plan.    
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Figure 48:  Isodose plots of TPS calculated dose distributions for 
irradiation of the pentagon target in the polystyrene phantom for (a) the 
standard applicator plan and (b) the variable-SCD applicator plan.  (figure 
continued)  
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Figure 49:  Cumulative DVHs for the pentagon target showing PTV and 
Outside PTV ROIs.  The standard trial is represented by dotted lines and 
the variable-SCD trial by solid lines. 
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Table 7:  Summary of treatment planning results for irradiation of the 
pentagon target using the standard and variable-SCD methods.  
Pentagon target 
Trial ROI 
Mean 
Dose 
(%) 
σ 
(%) 
Min 
(%) 
Max 
(%) 
D90-10
(%) 
Standard PTV 99.2 3.6 88.4 109.6 8.8 
Variable-SCD PTV 99.0 2.2 90.8 105.2 5.8 
Standard Outside PTV 45.7 32.9 4.4 107.4  
Variable-SCD Outside PTV 45.1 31.9 4.4 104.2  
 
The unmatched penumbra in the standard applicator plan resulted in a hot spot as 
great as 110% in the PTV, which was reduced to 105% in the variable-SCD applicator 
plan.  This limited reduction in magnitude is due to the 12 MeV beam penumbra 
becoming broader than that of the 20 MeV beam at depths greater than 1.5 cm (cf. Figure 
35).  As in the case of the two-step block target, the hot spot in the standard plan overlaps 
the PTV and Outside PTV ROIs resulting in a hot spot of 107% outside the target.  
Therefore, a 3% reduction in dose spread and σ outside the target is provided by the 
penumbra matching of the variable-SCD applicator.  As expected, the reduction in mean 
dose outside the target is less than 2%.     
3.4.1.4  Inverted Well Target 
This target was divided into three regions, regions 1 and 3 having a maximum 
distal target depth of 5.5 cm and region 2 having a maximum distal target depth of 3.5 
cm.  A 20 MeV beam (R90 = 5.9 cm) was selected to treat regions 1 and 3, and a 12 MeV 
beam (R90 = 3.9 cm) to treat region 2.  The 20 MeV beams (defined using two separate 
blocks) for regions 1 and 3 were defined with inner edges at ±2 cm respectively and the 
outer edges placed 2 cm beyond the outer boundaries of regions 1 and 3 at ±7 cm off-
axis.  Beam edges were defined for the center 12 MeV beam (region 2) at ±2 cm off-axis 
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to match the 20 MeV beams.  The central 12 MeV beam normalization point (0 cm off-
axis, 2.7 cm depth) was chosen as the reference point for the composite dose distribution.  
Beam weights were assigned with 47 MU (33.8%) to each of the two 20 MeV beams and 
45 MU (32.4%) to the 12 MeV beam.  
Treatment planning dose distributions using the standard and variable-SCD 
applicators are presented in Figure 50a and 50b, respectively.  The DVHs for both trials 
are overlaid in Figure 51 and the DVH statistics are summarized in Table 8.   
The variable-SCD applicator plan in Figure 50b provided a visibly more uniform 
dose distribution than the standard applicator plan in Figure 50a.  This is reflected in the 
variable-SCD applicator's significantly steeper DVH and 35% reduction in σ, 43% 
reduction in D90-10, and 31% reduction in dose spread.  The unmatched penumbra in the 
standard applicator plan resulted in a cold spot in the PTV as low as 85% and a hot spot 
as great as 108%.  There remained in the variable-SCD applicator plan (1) a small cold 
spot of 88% due to the 20 MeV penumbra being greater than the 12 MeV penumbra at 
depths less than 1.5 cm (cf. Figure 35), and (2) a small hot spot of 104% due to the 12 
MeV beam penumbra being greater than that of the 20 MeV beam at depths greater than 
1.5 cm.   
The small 103% hot spot outside the target due to unmatched penumbra in the 
standard applicator plan was reduced to 100% in the variable-SCD applicator plan, and a 
slight increase in the minimum dose outside the target was seen.  This resulted in the dose 
spread outside the target being reduced by 4% as well as a 6% reduction in σ.  As 
expected, a negligible change was seen in mean dose outside the target.    
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Figure 50:  Isodose plots of TPS calculated dose distributions for 
irradiation of the inverted well target in the polystyrene phantom for (a) 
the standard applicator plan and (b) the variable-SCD applicator plan.   
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Figure 51:  Cumulative DVHs for the inverted well target showing PTV 
and Outside PTV ROIs.  The standard trial is represented by dotted lines 
and the variable-SCD trial by solid lines. 
 
Table 8:  Summary of treatment planning results for irradiation of the 
inverted well target using the standard and variable-SCD methods.  
Inverted well target 
Trial ROI 
Mean 
Dose 
(%) 
σ 
(%) 
Min 
(%) 
Max 
(%) 
D90-10
(%) 
Standard PTV 97.4 4.6 84.8 108.2 13.8 
Variable-SCD PTV 97.4 3.0 87.6 103.8 7.9 
Standard Outside PTV 61.4 26.4 8.6 103.0  
Variable-SCD Outside PTV 61.3 24.8 9.6 100.0  
 
3.4.1.5  Summary of Treatment Planning Results 
 The results of treatment planning PTV dose statistics for the four simulated 
targets using the standard applicator and the variable-SCD applicator are summarized in 
Table 9.   
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Table 9:  Summary of treatment planning results for dose to the four 
simulated PTVs using the standard and variable-SCD methods.  
Target Trial 
Mean 
Dose 
(%) 
Min 
(%) 
Max 
(%) 
Max-Min 
(%) 
σ 
(%) 
D90-10
(%) 
Std 97.6 78.0 108.5 30.5 4.2 10.3 
 Mod 97.2 85.8 102.8 17.0 3.2 7.7 
Std 97.6 88.7 104.2 15.5 2.8 7.4 
 Mod 97.6 89.1 103.0 13.9 2.4 6.1 
Std 99.2 88.4 109.6 21.2 3.6 8.8 
 Mod 99.0 90.8 105.2 14.4 2.2 5.8 
Std 97.4 84.8 108.2 23.4 4.6 13.8 
 Mod 97.4 87.6 103.8 16.2 3.0 7.9 
Average ↓ 0.2% ↑ 4% ↓ 4% ↓ 32% ↓ 29% ↓ 32% 
 
The mean dose decreased by 0.2% on average, indicating the total dose in the 
PTV was not impacted significantly using the variable-SCD applicator.  In all four cases, 
dose homogeneity in the PTV using the variable-SCD applicator was in agreement with 
the hypothesis, i.e. minimum PTV dose was ≥ 85% and maximum dose was ≤ 105%.  
Minimum dose was increased by 4% on average, and maximum dose was decreased by 
4% on average.  An average reduction of 32% in dose spread (maximum-minimum), 29% 
in the σ of the PTV dose distribution, and 32% in D90-10 indicate that treatment plans 
calculated using the variable-SCD applicator provide a substantial improvement in dose 
homogeneity over plans using the standard applicator.                  
3.4.2  Variable-SCD Plan Verification 
 The results of delivering the variable-SCD applicator plans, described in the 
previous section, are presented using isodose plots and off-axis profiles at 2 cm depth.  
The monitor units assigned to each beam in the treatment planning phase were delivered 
 80
to the polystyrene film phantom, and the composite measured dose distribution for each 
plan was normalized to 100% at the reference point defined in the treatment plan.  The 
measured dose distributions were compared with the TPS calculations to assess the 
ability to deliver the planned dose distributions.    
3.4.2.1  Two-step Block Target 
 The isodose plots and off-axis profiles at a depth of 2 cm for measured and 
calculated dose distributions for irradiation of the two-step block target using the 
variable-SCD applicator plan are overlaid in Figure 52a and 52b, respectively.  Depth 
dose curves at -3.4 cm and 2.6 cm off-axis are shown in Figure 53a and 53b, respectively.   
Field size agreement is seen comparing measured and calculated lateral dose 
falloffs at 2 cm depth in Figure 52b.  For depths greater than 2 cm, the 90% isodose 
region in Figure 52a agree within 2%, with the exception of a small region of 3% 
difference from -3 to -5.5 cm off-axis and 2 cm depth (cf. Figure 52b and 53a), where 
calculated dose overestimates measured dose.  This is likely due to beam output for the 9 
MeV beam using the variable-SCD applicator being less than the measured standard 
applicator output factors used in the treatment planning system.  For depths less than 2 
cm, the 90% isodose contours agree within 3%, with the exception of a region within ± 
0.5 cm of the abutment edge, where the measured dose is seen to be more uniform than 
calculated.  This resulted in the absence of the 86% cold spot predicted by the treatment 
plan.   
Differences as much as 5% due to the pencil-beam algorithm's overestimation of 
dose less than 20% in the falloff regions outside of the 9 MeV beam edges are seen from 
3 to 4 cm depth and -7.5 to -9 cm off-axis in Figure 52a.  Similar discrepancies are seen  
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Figure 52:  Measured (solid red) and TPS calculated (dashed black) dose 
data for irradiation of the two-step block target using the variable-SCD 
applicator plan. (a) Isodose plot of central xz plane dose distributions.  
Note:  The solid circle indicates the point at which the measured and 
calculated dose distributions are normalized to 100%. (b)  Off-axis dose 
profiles at 2-cm depth.  
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Figure 53:  Measured (solid red) and TPS calculated (dashed black) depth 
dose plots for irradiation of the two-step block target at (a) -3.4 cm off-
axis, and (b) 2.6 cm off-axis. 
 
 
outside the 16 MeV beam edges from 6 to 8 cm depth from 8 to 10 cm off-axis from -3 to 
-5 cm off-axis.  The influence of the latter discrepancies on depth dose in the region of 
the 9 MeV beam is evident in Figure 53a from 6 to 8 cm depth.  
3.4.2.2  Wedge Target 
 
The isodose plots and off-axis profiles at 2 cm depth for measured and calculated 
dose distributions for irradiation of the wedge target using the variable-SCD applicator 
plan are overlaid in Figure 54a and 54b, respectively.  The central-axis depth dose curves 
are shown in Figure 55.     
Agreement in lateral dose falloff in Figure 54b indicates field size agreement.  
Profile agreement at this depth is within 2% generally, with the exception of a region 
within ± 0.5 cm of the abutment edge of the 16 and 20 MeV beams, where calculation 
exceeds measurement by as much as 5%.  In Figure 54a, the measured dose is generally 
2% less than calculated in the region of the PTV covered by the 16 MeV beam.  This  
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Figure 54:  Measured (solid red) and TPS calculated (dashed black) dose 
data for irradiation of the wedge target using the variable-SCD applicator 
plan. (a) Isodose plot of central xz plane dose distributions.  Note:  The 
solid circle indicates the point at which the measured and calculated dose 
distributions are normalized to 100%. (b)  Off-axis dose profiles at 2-cm 
depth.  
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Figure 55:  Measured (solid red) and TPS calculated (dashed black) 
central axis depth dose plots for irradiation of the wedge target. 
 
effect may be due to 16 MeV beam output for this field size (3x12 cm2) using the 
variable-SCD applicator being less than the standard applicator output factors used in the 
TPS calculation.  More clinically significant, however, is the 6% measured dose 
deficiency (1 cm DTA) at the 90% isodose in the region covered by the 16 MeV beam 
(cf. Figure 55).  This discrepancy is likely due to a combination of inaccurate beam 
output and the dose algorithm's overestimation of the low dose contribution of the 12 
MeV beam between 4 cm and 6 cm depth (cf. Figure 38).     
3.4.2.3  Pentagon Target 
The isodose plots and off-axis profiles at 2 cm depth for measured and calculated 
dose distributions for irradiation of the pentagon target using the variable-SCD applicator 
plan are overlaid in Figure 56a and 56b, respectively.  The central-axis depth dose curves 
are shown in Figure 57.     
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Figure 56:  Measured (solid red) and TPS calculated (dashed black) dose 
data for irradiation of the pentagon target using the variable-SCD 
applicator plan. (a) Isodose plot of central xz plane dose distributions.  
Note:  The solid circle indicates the point at which the measured and 
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calculated dose distributions are normalized to 100%. (b)  Off-axis dose 
profiles at 2-cm depth.  
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Figure 57:  Measured (solid red) and TPS calculated (dashe
central axis depth dose plots for irradiation of the pentagon target. 
 
Agreement in lateral dose falloff (< 1 mm DTA) in Figure 56b indica
a
2%, while the measured dose in the regions of the two 12 MeV beams is less than 
calculated by as much as 5%.  This difference in percent dose is seen between 2 cm and 4 
cm depth in the PTV, and is likely due to output for the 12 MeV beams using the 
variable-SCD applicator being less than the standard applicator output factors used in the 
TPS calculations.  Further, between ±3 cm off-axis for 4-6 cm depths, measured d
less than calculated dose by as much as 4%.  Discrepancies in this region are most 
significant on central axis (Figure 57), and are clearly due in part to the dose algorithm's 
overestimation of low dose (< 20%) contributions for the 12 MeV beams (cf. Figure
From 80% to 10% however, central-axis depth dose agreement is within 2 mm DTA.  
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The central axis depth dose curve in Figure 57 also exhibits a difference of as much as 
5% from 0.5 to 2 cm depth, where calculated dose exceeds measured.  This difference i
consistent with the commission verification results (cf. Figure B9), and is likely due to 
depth dose curves measured using the standard applicator being used to calculate the 
variable-SCD applicator dose distribution.   
3.4.2.4  Inverted Well Target 
The isodose plots and off-axis profile
s 
s at 2 cm depth for measured and calculated 
 of the inverted well target using the variable-SCD 
applica
 
in 1%, with 
the exc
 
 
 in 
dose distributions for irradiation
tor plan are overlaid in Figure 58a and 58b, respectively.  Depth dose curves at 0 
cm and -3.4 cm off-axis are shown in Figure 59a and 59b, respectively.       
Agreement in lateral dose falloff (< 1 mm DTA) in Figure 58b indicates field size
agreement.  At this depth, measured and calculated dose generally agree with
eption of dose to points at ±1 cm from central-axis, where agreement is within 
2%.  Similarly, agreement in the PTV for depths greater than 2 cm is within 2%.  The 
measured hot spot (105.7%) at -2.8 cm off-axis and 3.5 cm depth is approximately 1.7%
greater than the TPS predicted at that point.  This may be due to a slight beam overlap 
(probably less than 0.3 mm).  The symmetric discrepancy in the 90% and 95% isodose 
contours from 3 to 4 cm off-axis and from -3 to -4 cm off-axis is again due to the dose 
algorithm's overestimation of the low dose contribution of the 12 MeV beam.  Similar 
effects due to the 20 MeV beam are seen in the 30% and 10% isodose contours between
±2 cm off-axis.  The influence of these discrepancies on central axis depth dose is seen
Figure 59a from 7 to 11 cm depth where calculated dose exceeds measured dose by as 
much as 8%.  Also, due to measured depth dose curves for the standard applicator being  
 88
  
 
 
 
 
igure 58:  Measured (solid red) and TPS calculated (dashed black) dose 
ata for irradiation of the inverted well target using the variable-SCD 
applicator plan. (a) Isodose plot of central xz plane dose distributions.  
ote:  The solid circle indicates the point at which the measured and 
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profiles at 2-cm depth. 
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used to se exceeds 
measur % on central axis (Figure 59a) from 0.5 to 1 cm depth, 
 
 
igure 59:  Measured (solid red) and TPS calculated (dashed black) depth 
ose plots for irradiation of the inverted well target at (a) 0 cm off-axis, 
nd (b) -3.4 cm off-axis. 
3.5  Ai
The results of segmentation-field treatment plans developed for the patient case 
iable-SCD applicators 
, and 
 
 calculate the variable-SCD applicator dose distribution, calculated do
ed dose by as much as 6
and by as much as 8% at -3.4 cm off-axis (Figure 59b) from 0.5 to 2 cm depth.    
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m 4b:  Treatment Planning Results in Patient PTV          
 
(squamous cell carcinoma of the left ear) using the standard and var
are presented in this section.  Figure 60 shows the field segmentation scheme and 
locations of CT slices presented in this section.  Dose distributions (normalized such that 
5000 cGy = 90%) calculated using both applicators are shown for CT slices 73, 94
110 in Figures 61, 62, and 63, respectively. 
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Figure 60:  Sagittal view of the field segmentation scheme showing 
locations of transverse slices 73, 94 and 110 (z = 1.5, -4.5, and -9.3 cm
tively). 
 
 
(a) (b) 
Figure 61:  TPS dose distributions in transverse slice #73 calculated using 
(a) the standard applicator, and (b) the variable-SCD applicator.  Two 12 
MeV beams and a 16 MeV beam were used to treat this portion of the 
PTV.  The PTV is contoured in lavender and the cord in yellow.    
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Figure 62:  TPS dose distributions in transverse slice #94 calculated usi
(a) the standard applicator, and (b) the variable-SCD applicator.  A
ng 
 9 MeV 
beam, two 12 MeV beams, and a 20 MeV beam were used to treat this 
portion of the PTV. 
 
 
 
 
 
Figure 63:  TPS dose distributions in transverse slice #110 calculated 
using (a) the standard applicator, and ) the variable-SCD applicator.  A 9 
MeV and 12 MeV beam were used to treat this portion of the PTV.  The 
eye is contoured in skyblue and the lacrimal gland in green.  The white 
strip over the eye is the lead shield.     
 
(a) (b) 
(b) (a) 
(b
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In slice 73 (Figure 61), a hot spot of 111% using the standard applicator was 
reduced to 108% using the variable-SCD applicator.  In slice 94 (Figure 62), a more 
dramatic reduction in maximum dose is seen (114% to 108%) due to 12 MeV and 20 
MeV being non-adjacent energies.  Conversely, the modest reduction in the maximum 
PTV dose (103% to 102%) in slice 110 (Figure 63) is attributed to 9 MeV and 12 MeV 
being adjacent beam energies.  Also, a cold spot of 85% in slice 94 for the standard 
applicator plan (due to a slight beam gap along the anterior abutment edge of the 12 MeV 
and 20 MeV beams) is increased to 90% in t
re 
summa e limits 
r both ived less 35 Gy and the cord, eye, and 
optic n
le-
 
d 
ess 
signific
or 
s where the 
he variable-SCD applicator plan.      
The DVHs for both trials are overlaid in Figure 64, and the DVH statistics a
rized in Table 10.  The dose to the critical structures was within acceptabl
 plans.  95% of the lacrimal gland recefo
erve doses were well under tolerance dose (45 Gy, 50 Gy, and 50 Gy, 
respectively).  Dose homogeneity in the PTV was improved significantly in the variab
SCD applicator plan.  This is reflected by the σ of the PTV being reduced by 22%, the
minimum dose being increased by 14%, the maximum dose being decreased by 10%, an
the D90-10 dose spread decreasing by 22%.  Compared to the treatment planning results 
for simple PTVs, these results show a more significant improvement in the maximum 
PTV dose (4% reduction compared to 10% reduction) and minimum PTV dose (4% 
increase compared to 14% increase), while the improvements in σ and D90-10 are l
ant (30% reductions compared to 22% reductions).    
The 66% cold spot in the standard applicator plan occurs at the junction of the 12 
MeV and 20 MeV beams.  This cold spot was eliminated in the variable-SCD applicat
plan.  The remaining 75% cold spot in the variable-SCD applicator plan occur
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PTV nearly intersects the lacrimal gland and is a result of the efforts to minimize dose to 
the lacrimal gland and eye, i.e. the dose at the location of the cold spot could be increas
at the expense of increased dose to the critical structures.                 
ed 
 
Figure 64:  Cumulative DVHs for segmented-field ECT patient plan using 
the standard applicator (dashed lines) and the variable-SCD applicator 
(solid lines).  Dose to the PTV (lavender), lacrimal gland (green), eye 
(skyblue), cord (yellow) and optic nerve (red) are shown. 
 
Table 10:  Summary of treatment planning results for patient plan using 
the standard and variable-SCD applicators.    
Trial ROI 
Mean 
Dose 
(%) 
Min 
(%) 
Max 
(%) 
Max-Min 
(%) 
σ 
(%) 
D90-10
(%) 
Standard PTV 98.6 66.2 124.3 58.1 5.4 13.9 
Variable-
SCD PTV 98.0 75.3 111.5 36.2 4.2 10.9 
Percent Difference ↓ 0.6% ↑ 13.7% ↓ 10.3% ↓ 37.7% ↓ 22.2% ↓ 21.6% 
 
PTV 
Lacrimal  
Eye 
Gland 
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The limitations of the planning tools made segmented-field optimization 
prohibitively time consuming.  As such, a limited number of variations on this plan were 
investigated.  For example, the 112% hot spot occurs in the region of the 20 MeV field.  
A 20 MeV beam was selected to treat the deepest portion of the PTV because a 16 MeV 
beam would not provide ad enetration for the field size used (approximately 3x3-
cm2).  However, one could increase the penetration of the 16 MeV beam by increasing 
the field size, which may result in a less conformal dose distribution, but would decrease 
the magnitude of the hot spot in the PTV. 
            
      
 
 
 
 
 
 
 
 
 
equate p
 
 
 
          
 95
Chapter 4 
 
The results of this research support the hypothesis that a clinically practical 
method that utilizes Cerrobend® custom in
Conclusions 
serts can deliver segmented-field electron 
Vs, i.e. constrain the PTV dose to 85%-
05%. 
Four specific aims were completed to test the hypothesis.  In Aim 1, air gaps were 
lected (5, 7.5, 11.5, 17.5, and 19.5 cm for 6, 9, 12, 16, and 20 MeV beams respectively) 
r implementation of the variable-SCD method and a standard 15x15-cm2 applicator was 
odified to allow collimator placement at the selected locations.   
In Aim 2, the ability of the TPS to accurately calculate dose in a phantom using 
e standard and variable-SCD applicators was assessed.  The results showed that the 
lectron pencil-beam algorithm commissioned for the variable-SCD applicator using the 
andard applicator commissioning data predicts measured relative dose distributions 
ith the same degree of accuracy as it does for the standard applicator at 100 cm SSD.   
In Aim 3, a method of fabricating Cerrobend® inserts with diverging edges to 
efine precise field shapes was developed and the accuracy of beam collimation for 
 show that 
field edges can be abutted with ±0.3 mm  This resulted in ±2.2% dose variation 
 the abutment region at a depth of 1 cm for a 12 MeV beam, which should be typical of 
all beam
conformal therapy in the energy range of 6-20 MeV with less than ±5% variation in dose 
spread in abutment regions of hypothetical PT
1
se
fo
m
th
e
st
w
d
abutted fields using the variable-SCD applicator was evaluated.  The results
 accuracy. 
in
 energies using the variable-SCD applicator due to the penumbra widths 
matching.     
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In Aim 4a, segmented-field plans for the irradiation of four hypothetical PTVs 
were developed using the standard and variable-SCD applicators.  The ability to deliver 
the variable-SCD plans was assessed by irradiating a film phantom.  Treatment plans for 
the fou
%, indicating that the 
improv
r 
abutme d 
se 
hould be possible to significantly improve calculated and measured dose 
distribu m 
r simulated PTVs showed dose homogeneity in agreement with the hypothesis can 
be achieved using the variable-SCD applicator.  On average, the minimum dose increased 
4%, maximum dose was decreased 4%, the σ of the dose decreased by 29%, and D90-10 
decreased by 32%.  Mean dose was decreased by an average of 0.2
ement in dose homogeneity did not impact the total dose to the PTV.  In cases 1, 
3, and 4, unacceptable maximum and minimum dose in the PTV for the standard plan 
was reduced to acceptable levels (85%-105%) in the variable-SCD plan.   
The results of film phantom measurements showed the variable-SCD applicato
plans can be delivered with the predicted improvement in dose homogeneity in the 
nt regions.  However, significant disagreement between calculated and measure
dose distributions in central-axis depth dose (as much as 1 cm DTA in the 90% isodo
contours) was observed in case 2.  This is likely due to (1) the limitations of the dose 
algorithm in low dose regions (<20%) and (2) output factors measured using the standard 
applicator being used for the variable-SCD treatment plans.  Also, the 2% tolerance on 
clinical accelerator output may have contributed to the discrepancies observed.  
Therefore, it s
tion agreement by (1) using a more accurate dose algorithm (e.g. the pencil-bea
redefinition algorithm or Monte Carlo), and (2) fully commissioning the variable-SCD 
applicator.   
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In Aim 4b, the potential to improve dose homogeneity for a patient PTV was 
assessed by developing a treatment plan for a single patient case.  Comparison of 
identical plans using the standard and variable-SCD applicators with four beam energies 
show that dose homogeneity can be substantially improved using the variable-SCD 
applicator.  A 22% reduction was seen in the standard deviation and D90-10 of the PTV 
dose distribution.  The minimum dose was increased from 66% to 75% (a 14% increase) 
and the
s 
(3) 
of the variable-SCD method, (2) treatment planning, and (3) verification of 
patient ing 
al air 
 gaps 
 maximum dose was decreased from 124% to 112% (a 10% decrease).  The 
magnitude of the remaining hot could be reduced at the expense of decreased 
conformality by substituting a 16 MeV beam in the place of the 20 MeV beam and 
increasing the field size.  The remaining cold spot could be increased in dose at the 
expense of increased dose to critical structures.  Other possible sources of dose 
heterogeneity in both plans include (1) the definition of pencil beam locations for each 
field, i.e. field dimensions were not multiples of the 2x2 mm2 pencil beams, (2) field gap
and overlaps due to the limited treatment planning field-segmentation tools, and 
irregular patient surface and variations in tissue density.        
• Future Studies 
Future work that would build upon this research should be focused on (1) 
optimization 
plans.  The air gaps used in this research were chosen with the goal of optimiz
abutment dosimetry for any combination of beam energies.  Investigation of optim
gaps for subsets of energy combinations would likely yield different results, possibly 
further improving dose homogeneity.  For example, one might developed a set of air
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for the 6 MeV, 9 MeV, and 12 MeV beams to be used for shallow PTVs and another set 
of air gaps for deeper PTVs using the 12 MeV, 16 MeV, and 20 MeV beams. 
In regards to treatment planning, two tools could be developed to aid in
segmentation.  Firstly, a beams-eye view "depth map" is essential to allowing the us
choose appropriate beam energies and field shapes to treat the target volume.  While
method presented in this work is effective, an automated method would be prefe
clinical implementation.  Secondly, a TPS feature to automatically adjust block 
definitions such that gaps and overlaps are disallowed when a single block definition is 
modified would greatly reduce planning time.   
The ability to deliver patient treatment plans using mu
 beam 
er to 
 the 
rable for 
ltiple energy-segmented 
l r study.  The results of plan verification for simple hypothetical 
PTVs s
.  
fie ds requires furthe
howed substantial discrepancies in depth dose which was attributed to the 
limitations of the pencil-beam dose algorithm as well as the output factors measured 
using the standard applicator being used for the variable-SCD applicator plans.  Because 
of increased complexity in patient plans, these discrepancies could possibly be increased
Therefore, a study of plan verification for patient plans calculated using the standard 
pencil-beam algorithm, the pencil-beam redefinition algorithm, and Monte Carlo methods 
would be prudent and should coincide with an investigation into the influence of the 
increased air gaps on beam output.                    
Assessment of the potential for the variable-SCD method to deliver dosimetry 
comparable to bolus electron conformal therapy in patient PTVs also requires further 
study.  Ideally, these studies would be carried out using patient cases treated using 
custom bolus or by developing custom bolus and variable-SCD plans for patient cases. 
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• Technology Required for Clinical Implementation 
The variable-SCD method results in broadened penumbra for all beam edges, 
regardless of whether the edges is abutted to another field or is an outer edge.  This 
results 
p) in 
allow 
  
al 
e of 
ted at 95-cm SCD, the currently standard 
insert l
t can 
 
 
 
in increased dose to normal tissue; however, the method could be improved by 
defining a single outer-field-edge collimator at the standard location (e.g. 5-cm air ga
addition to the abutment-field-edge collimators at the variable SCDs.  This would 
for sharp lateral dose falloff, sparing normal tissue around the perimeter of the target.
While this is currently practical with the variable-SCD applicator, the treatment planning 
system does not allow for such a setup. 
For the method to be implemented clinically on a routine basis, there are sever
technologies that need to be commercially available.  Specifically, they include: (1) 
variable-SCD applicators for the treatment machine, including allowing the outer edg
all fields to be defined by a common insert loca
ocation; (2) improved treatment planning tools for creating the BEV depth map 
and accomplishing segmentation of the treatment field into optimal subfields for each 
beam energy; and (3) dose calculations that are more accurate than the PBA and tha
model the multiple collimation levels. 
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Appendix A 
Variable-SCD Applicator Design 
 
Detailed drawings of the components of the variable-SCD applicator are 
presented in this appendix.  All dimensions are in centimeters.    
  
(a) (b)
Legs
Back plate Back plate 
Tabs 
with 
holes 
Tabs 
without 
holes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1:  3D view of the leg and back plate design with (a) tabs housing 
frame alignment holes attached and (b) tabs without alignment holes 
attached.       
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A2:  (a) Front view of leg and back plate design with tabs in place.  
Threaded holes for tab attachment are shown.  (b) Rear view of leg and 
back plate design.   
(b)(a) 
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Figure A3:  Front view of leg design detailing dimensions concerning tab 
placement and spacing.  Note: the holes in this figure were threaded for a 
4-40 screw.     
 
 
 
 
 
 
 
 105
 
 
 
 
 
 
(a) 
(b) 
(c) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4:  (a) 3D view of tab design showing tab dimensions. (b)  Top 
view of tab showing placement and dimensions of alignment holes.  (c) 
Front view of tab showing placement and dimensions of holes (not 
threaded) used for leg attachment.   
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Figure A5:  3D view of frame design detailing all dimensions including 
peg diameter.     
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Appendix B 
15x15-cm2 Isodose Plots 
 
Isodose plots of measured and TPS calculated dose distributions for 15x15-cm2 fields using the standard and variable-SCD 
applicators are presented in this appendix.    
Figure B1:  Isodose plots for 6 MeV, 15x15-cm2 field measured (solid line) and calculated (dashed line) using the 
standard 5-cm air gap. 
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Figure B2:  Isodose plots for 9 MeV, 15x15-cm2 field measured (solid line) and calculated (dashed line) using the 
standard 5-cm air gap. 
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Figure B3:  Isodose plots for 9 MeV, 15x15-cm2 field measured (solid line) and calculated (dashed line) using the 
variable-SCD method with a 7.5-cm air gap. 
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Figure B4:  Isodose plots for 12 MeV, 15x15-cm2 field measured (solid line) and calculated (dashed line) using the 
standard 5-cm air gap. 
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 Figure B5:  Isodose plots for 12 MeV, 15x15-cm2 field measured (solid line) and calculated (dashed line) using the 
variable-SCD method with a 11.5-cm air gap. 
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Figure B6:  Isodose plots for 16 MeV, 15x15-cm2 field measured (solid line) and calculated (dashed line) using the 
standard 5-cm air gap. 
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Figure B7:  Isodose plots for 16 MeV, 15x15-cm2 field measured (solid line) and calculated (dashed line) using the 
variable-SCD method with a 17.5-cm air gap. 
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Figure B8:  Isodose plots for 20 MeV, 15x15-cm2 field measured (solid line) and calculated (dashed line) using the 
standard 5-cm air gap. 
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Figure B9:  Isodose plot for 20 MeV, 15x15-cm2 field measured (solid line) and calculated (dashed line) using the 
variable-SCD method with a 19.5-cm air gap.     
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